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Abstract 
 
Innate and adaptive immunity have classically been considered as two distinct categories 
of cells and responses. Recently, however, an increasing appreciation for the dynamic 
interactions between these responses has developed. In this dissertation, this overlap is 
explored in the context of Th1 CD4 T cell production of IFN-γ (interferon-gamma) in 
response to innate stimuli. In particular, we first asked what triggers innate stimulation of 
Th1 cells, examining multiple ligands, infections and time points to show that this 
response occurred within broad contexts of intracellular infection. We then asked how T 
cells are able to recognize innate stimuli, focusing on whether the T cell intrinsic 
response relied upon direct LPS (lipopolysaccharide) recognition or indirect recognition 
of secondary signals. T cell intrinsic requirements were examined in mixed bone marrow 
chimeras that allowed T cells to be compared within the same environment. Upon 
demonstrating that the innate Th1 cell response required IL-18 (interleukin-18) receptor 
signaling, we next explored how T cell extrinsic PRRs (pattern recognition receptors) 
elicit effector functions through IL-18 secretion. Here, we showed a dual requirement for 
both TLR4 (toll-like receptor 4) and inflammasome pathways after LPS stimulation 
during Salmonella infection. The convergence of these pathways was required for 
increased IL-18 secretion, suggesting a dual level of control in production of such a pro-
inflammatory cytokine. Finally, we asked whether the innate stimulation of Th1 cells is a 
required response pathway during clearance of Salmonella. Using Lck-cre x MyD88-loxP 
crossed mice, we demonstrated a deficiency in bacterial clearance in the absence of the 
signaling molecule MyD88 within T cells, which impairs the ability of Th1 cells to 
respond to IL-18, but not classical antigen stimulation. Together, this data suggests that 
the Th1 cell response utilizes a pathway of innate stimulation to amplify IFN-γ 
production under situations of severe inflammation, in which the classical adaptive 
response pathway may not be sufficient to mediate a strong and rapid response. Future 
work may explore additional infectious contexts, other CD4 T cell subsets, memory 
responses, and circumstances of immunopathology. 
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Overview 
In the earliest studies of immunology the categorical distinction between innate and 
adaptive immunity was a critical framework for further understanding the mechanisms of 
each. However, as we expand our understanding of the complex networks of cells and 
cytokines, transcription factors and molecular memory, interactions and responses, it 
becomes clear that any framework we place upon the immune system is an 
approximation just waiting for an exception. Some of these exceptions are nominal; 
artifacts of culture systems or the tools available, that may ultimately prove interesting 
but meaningless. However, many of these exceptions prove to be details in a bigger 
picture we simply haven’t uncovered yet. We now know that the innate and adaptive 
immune responses are not separate systems. They are an interwoven and often 
overlapping series of events that have evolved around the central goal of a 
simultaneously rapid, effective and controlled defense against self damage.   
During an infection, pattern recognition receptors (PRRs), including toll-like receptors 
(TLRs) and nod-like receptors (nucleotide-binding oligomerization domain, NLRs), 
recognize conserved molecular patterns- that is, molecules or motifs that could be 
produced during many different types of infection. These molecular patterns can be 
generated by the microbe itself or by the damage it inflicts. Microbe-associated molecular 
patterns, or MAMPs, include many common constitutents of pathogens, such as the Gram 
negative cell wall component lipopolysaccharide (LPS). On the other hand, damage-
associated molecular patterns (DAMPs) are less well described, but include cellular 
products typically only found in a particular location under cellular stress or death, for 
example DNA in the cytoplasm or extracellular space is recognized by several PRRs as a 
sign of host cell damage (Tang et al., 2012). Together, these conserved molecular 
patterns are the first indication of a potential problem for the host, and their broad pattern 
recognition is a defining characteristic of the innate immune response, shown in the 
bottom box of Figure A-1. These innate responses are often thought of in the context of 
innate cell activation or early inflammatory cytokine production, for example, dendritic 
cell (DC) activation and production of interleukin-1 (IL-1). However, it has been 
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observed under various conditions that sometimes these innately recognized molecules 
trigger traditionally “adaptive” responses, both for TLR- (Dillon et al., 2004; 
Manicassamy and Pulendran, 2009; Tough et al., 1997) and NLR-recognized ligands 
(Dunne et al., 2010; Ritter et al., 2010; Trunk and Oxenius, 2012).  
While innate immunity can be defined by its recognition of broadly conserved microbial 
patterns, the adaptive immune response is distinguished by the specificity and 
simultaneous breadth of its antigen receptors. On T cells, the T cell receptors (TCRs) 
rearrange during initial development to recognize a different peptide sequence for each 
different T cell. These peptides are presented on the surface of an interacting cell within 
the major histocompatability complex (MHC). TCR interaction with the specific peptide 
sequence and MHC recognized by it is also called cognate or antigen-specific activation, 
illustrated in the top panel of Figure A-1. This recognition of a specific peptide sequence/ 
MHC pair makes activation of an individual T cell relatively uncommon, while the 
recognition of many different peptide sequences by the full T cell repertoire gives T cells 
a powerful capacity to respond to a broad variety of potential challenges. Much of this 
work will focus on T cell interactions that occur subsequent to and independent of these 
specific TCR interactions, thus to distinguish TCR-dependent and –independent signals 
these interactions are often referred to as non-cognate.  
Here, we focus on a classical example of adaptive immunity, the effector response of 
CD4 T helper subset 1 (Th1) cells during intracellular infection. CD4 T cells may 
differentiate into various subsets with distinct functions, but during infections with 
endosomally-enclosed pathogens, the ability of Th1 cells to produce IFN-γ and thereby 
activate macrophages is a critical requirement of pathogen control and clearance. Th1 cell 
activation, differentiation, stimulation, effector function, and memory formation will be 
discussed in greater detail in later sections, but it is important to note here that all of these 
topics are classically considered in the discussion of adaptive immune responses because 
T cells are primarily described as an adaptive, cognate-antigen specific cell type. The Th1 
subset can be identified by its expression of the transcription factor T-bet, and the 
production of effector cytokines that include IFN-γ, TNF-α and IL-2. These functions are 
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typically attributed to direct interactions between T cells and APCs presenting cognate 
antigen, which prevents unnecessary or off-target inflammation. It has been observed, 
however, that T cells can also respond in a variety of different ways to non-cognate 
stimuli (Berg and Forman, 2006; Freeman et al., 2012; Pien et al., 2002). 
Characterizing these “innate-like” responses is critical to a full understanding of T cell 
function, including clearance of infection and autoimmune pathologies. In this work, we 
discuss what is currently known about innate T cell responses, and then focus on 
elicitation of the critical effector cytokine IFN-γ by LPS to further elucidate a kinetic, 
mechanism, and role for this non-traditional Th1 response during intracellular bacterial 
infections.  
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Figure A-1: Signals of conventional innate and adaptive immunity 
The immune response is traditionally divided into 2 arms: the rapid, germ-line encoded innate 
immune responses, and the RAG-optimized adaptive immune responses. Adaptive immunity (top 
panel) includes the T cell response. Activation of T cells relies upon 3 key signals: TCR 
recognition of peptide presented in the MHC, co-stimulatory interactions, and cytokines that 
instruct differentiation. Innate immunity (bottom panel) may also involve multiple signals: TLRs 
to upregulate IL-1 family cytokine precursor proteins, and NLRs to activate the caspases that 
cleave 2 of the IL-1 family members, IL-1 and IL-18, prior to secretion. We reconsider this model 
in the discussion. 
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Salmonella and other intracellular bacterial infections 
While most bacteria live and replicate extracellularly, entering the host cell only when 
engulfed and destroyed by phagocytes, some bacteria have adapted unique survival 
strategies to allow a protected life cycle within host cells. Some of these bacteria are 
obligate intracellular pathogens, like Chlamydia, that cannot replicate outside of the cell, 
but many bacteria are capable of occupying either space. The immune system has, in 
turn, developed a number of ways to recognize pathogens within cells, pathways which 
the pathogen actively attempts to thwart (Thi et al., 2012).  
This work primarily focuses on systemic infection of mice with Salmonella, a gram 
negative enteric pathogen that resides predominantly within the phagosomes of 
macrophages located in the spleen, liver, and bone marrow. In humans, there are two 
forms of systemic salmonelloses: typhoid fever and non-typhoidal salmonellosis, or NTS. 
Typhoid and paratyphoid fevers are caused by the human-specific pathogens Salmonella 
enterica serovar Typhi and Paratyphi, still occur endemically in developing countries, 
and can cause severe systemic disease even in healthy individuals. Estimates range as 
high as 27 million annual infections with either Typhi or the clinically indistinguishable 
Paratyphi. In contrast, NTS occurs only in immunocompromised individuals, but can 
originate from any of the ~2000 Salmonella serovars capable of causing foodborne illness 
in humans and harbored in a wide variety of animal reservoirs (Griffin and McSorley, 
2011). Thus, both systemic infections remain a source of concern for public health 
officials worldwide. 
Although antibiotics effective against Salmonella are available, the options are relatively 
limited for intracellular pathogens as compared to more accessible extracellular 
pathogens. Additionally, among those antibiotics currently available there is a growing 
incidence of drug resistance, including multi-drug resistance to the first-line treatments, 
and resistance to the now standard fluoroquinolones. Further, decreased susceptibility to 
the fluoroquinolone ciprofloxacin has been associated in enteric fever patients with 
prolonged fever and increased rates of treatment failure (Crump and Mintz, 2010). 
Finally, an analysis of the Salmonella metabolic pathways has suggested that most of the 
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major or non-redundant pathways have already been targeted or considered for drug 
inhibition, suggesting a limitation to prospective future development of new antibiotic 
treatments (Becker et al., 2006). Together, these studies emphasize the need for 
alternative treatment options and for improved vaccination strategies that could lessen the 
need for, and consequently the selective pressure upon, traditional antibiotic therapy. 
Currently, two vaccinations are commercially available in the U.S. for travelers to 
typhoid endemic countries. One is a Vi capsular polysaccharide (ViCPS) vaccine 
administered intramuscularly as one dose at least one week prior to exposure. The second 
is an oral, attenuated Ty21a vaccine available under several formulations, typically 
administered every other day as 3 separate doses two weeks prior to exposure. Both 
vaccinations suffer from limitations that impair their practicality in typhoid endemic 
regions, not the least of which is the need for regular re-vaccination, and the low reported 
efficacy at 3 years of 51-55% (Fraser et al., 2007). The ViCPS vaccine is approved in 
children over the age of two years old, and the oral vaccine for children over the age of 5 
years, while repeated exposure before the age of 5 in endemic areas has been shown. In 
addition, while evidence suggests that Ty21a may be cross-protective for paratyphoid, the 
ViCPS vaccine targets an antigen that does not exist in Paratyphi and some strains of 
Typhi (Crump and Mintz, 2010; Pakkanen et al., 2012). Further, because the oral vaccine 
is a live, attenuated Salmonella strain, it is not suitable for use in immune-compromised 
patients, posing a challenge to widespread use in areas co-endemic for HIV. Thus, 
currently available vaccination strategies are not adequate to allow control of systemic 
typhoidal disease (Fraser et al., 2007). Whether currently available vaccines mediate any 
protection to non-typhoidal systemic diseases has not been thoroughly characterized. This 
data emphasizes a need to better understand the immune response during systemic 
Salmonella infections, to inform better vaccine design. 
The role of Th1 cells and IFN-γ in intracellular infections 
As mentioned earlier, some bacteria and other pathogens have developed the capacity to 
reside within cells and effectively hide from extracellular immune recognition. Often, 
these pathogens enter the cells initially using the cells’ own phagocytic capacity, but then 
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are able to escape phagolysosomal degradation or escape the phagosome entirely, by a 
wide range of different mechanisms (Pluddemann et al., 2011; Thi et al., 2012). Given 
this unique lifestyle, intracellular pathogens require a special type of immune response 
designed to recognize infected phagocytes and mediate either killing of the infected cell 
or internal pathogen killing mechanisms. CD8 T cells have cell-specific cytotoxic 
capacity, allowing directed killing of infected cells, while both CD8 and CD4 T cells can 
secrete pro-inflammatory cytokines that activate phagocytes to initiate internal 
mechanisms of pathogen destruction. 
CD8 T cells have multiple cytolytic capacities initiated by TCR interactions, including 
release of secretory granules and death receptor-mediated apoptosis. However, while 
these responses have a critical role in anti-viral defenses, their role against other 
intracellular pathogens is limited. (Lewinsohn et al., 2011). Of more importance to 
intracellular bacterial infections, CD8 can produce pro-inflammatory cytokines such as 
IFN-γ, which activates macrophages to undergo changes that alter the intracellular 
environment to become less hospitable to the invading pathogen. While CD8 T cells 
respond to MHC-I that mostly present antigen processed from the cytosol, CD4 T cells 
respond to MHC-II presented antigen on special antigen-presenting cells derived from the 
endocytic pathway. This allows CD4 T cells to recognize antigens from pathogens hiding 
inside of cells within endosomes, as well as antigens taken up from outside of the cell 
(Neefjes et al., 2011). 
Among the various CD4 T cell subsets, the CD4 Th1 cells are the primary response to 
intracellular pathogens. CD4 differentiation and the other subsets will be discussed in 
more detail later, but in discussing the critical role of Th1 during intracellular infection it 
is important to first briefly define them. After CD4 T cells are activated they receive a 
differentiation signal that determines their cytokine profile. IL-12 upregulates the 
transcription factor T-bet, which is required by Th1 for IFN-γ production. (Geginat et al., 
2013). Once activated, Th1 cells are programmed to secrete pro-inflammatory cytokines 
that include IFN-γ, TNF-α, and IL-2 upon restimulation.  
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IFN-γ is especially important during intracellular infection, as mentioned above, because 
of its critical capacity to activate macrophages to become M1, or classically activated, 
macrophages. M1 macrophages modify their internal environment to become as 
inhospitable as possible, including production of anti-microbial compounds like reactive 
oxygen and nitrogen species, as well as themselves secreting pro-inflammatory cytokines 
(Murray and Wynn, 2011). The importance of IFN-γ-mediated macrophage activation is 
highlighted by the effects resulting from the loss of IFN-γ or IFN-γ-inducing cytokines 
and transcription factors (de Jong et al., 1998; Nyirenda et al., 2010; Ravindran et al., 
2005). In both mice and humans, loss of IFN-γ results in an inability to effectively clear 
intracellular pathogens (Jouanguy et al., 1999). Further, in humans with chronic 
granulomatous disease or mycobacterial granulomas, IFN-γ is an effective, albeit toxic, 
therapeutic (Ezekowitz et al., 1988; Holland et al., 1994; Marciano et al., 2004). 
Combined, these studies clearly demonstrate the requirement of IFN-γ for effective 
clearance of intracellular pathogens. 
Innate Immunity 
The innate immune system is classically defined by an early, rapid inflammatory 
response to broad molecular patterns (MAMPs and DAMPs). This response does not 
utilize recombinase-activated gene (RAG) mediated lymphocyte receptor rearrangement 
to improve diversity or specificity within its recognition repertoire, as is the case for the 
adaptive immune response. Instead, innate immune responses rely on conserved, 
germline-encoded receptors. As outlined in the overview, the response to MAMPs and 
DAMPs is mediated by a group of pattern recognition receptors (PRRs), of which the 
best-described examples include TLRs and NLRs, but which also includes RIG-I-like 
receptors (RLRs), C-type lectin receptors (CLRs), and others (Broz and Monack, 2013). 
Many types of cells have been found to express some type of PRR and participate in 
innate immune responses, but of particular importance to the early immune response are 
the phagocytes, including macrophages, DCs, mast cells and neutrophils. During an 
infection, professional phagocytes engulf pathogens and dead or dying cells to mediate 
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pathogen killing and wound healing, and are able to utilize PRRs to become rapidly 
activated (Pluddemann et al., 2011). 
Recognition of these patterns has evolved as an early warning system, a way for the 
immune system to recognize the presence of evolutionarily identified harmful situations. 
This allows these cells to act as the first responders to a potentially harmful situation, like 
an infection, but at the same time allows relatively liberal production of potentially 
harmful cytokines by the innately responding cell. To counterbalance this problem, these 
responses are generally self-limiting in strength and duration. In many situations the 
innate immune response will be sufficient to quickly resolve the infection, while in others 
it merely serves to minimize the host damage until the adaptive immune responses have 
had time to take over. 
The role of TLRs and NLRs in the early immune response to intracellular pathogens has 
been well defined (Broz and Monack, 2013; Franchi, 2011). TLRs are expressed on 
membranes, and as such generally responsible for the recognition of extracellular 
pathogens and cellular debris on the cell surface or intracellular pathogens and 
phagocytosed material within the endosome. Endosomal TLRs, including TLR3, 7 and 9, 
recognize foreign nucleic acids. Cell surface TLRs recognize a variety of foreign motifs 
that are generally conserved across many microbes, such as bacterial cell wall and 
membrane components. NLRs are cytoplasmic sensors that can recognize pathogen-
derived molecules or signs of cellular stress.  
Many different types of molecules can be ligands for PRRs, and these can originate from 
bacterial, viral, or parasitic pathogens, as well as from the host itself. Upon cell damage 
or necrotic cell death, endogenous host ligands can be released into inappropriate 
locations, e.g. nuclear contents into the cytosol or cytoplasmic contents into the 
extracellular space. Some common examples of PRR ligands recognized during 
Salmonella infection include the recognition of LPS by TLR4 or flagellin by either TLR5 
or NLRC4 (Broz and Monack, 2013). However, NLRP3 has also been shown to respond 
during Salmonella, possibly to LPS, or possibly to cell damage signals, since NLRP3 
recognizes a very broad list of ligands (Broz et al., 2010). 
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TLRs initiate a signaling cascade via the toll-IL-1 receptor (TIR) domain containing 
adaptor molecules MyD88 or TRIF that ultimately result in, among other things, the 
upregulation of the pro-inflammatory transcription factor NFκb . While most NLR family 
members are involved in assembly or signaling of a cytoplasmic sensor complex known 
as the inflammasome, a few exceptions exist that can also promote NFκb signaling or 
transcriptional activation independent of inflammasome complex formation, including 
NOD1 and NOD2. Historically, inflammasomes are assembled by NLRs to activate 
caspases that process IL-1, which can promote inflammation or lead to pyroptosis, a form 
of programmed cell death that allows internal pathogens to be re-exposed to external 
recognition receptors. These responses are part of the “canonical” inflammasome 
pathway, however “non-canonical” inflammasomes are also described that activate other 
caspases. (Broz and Monack, 2013).  
In particular, recent evidence has elaborated upon the interactions required for the 
assembly and function of the canonical NLRC4 inflammasome, which, as mentioned 
above, is a major PRR during Salmonella infection. A family of proteins called NAIPs 
(neuronal apoptosis inhibitory proteins) was shown to act as innate ligand sensors for 
flagellin and T3SS (type III secretion system) proteins. These NAIPs are then able to 
activate NLRC4 by an unknown mechanism, which facilitates its interaction with the 
adaptor protein ASC (apoptosis-associated speck-like protein containing a CARD), 
resulting in the cleavage of pro-caspase 1 into the active caspase 1. Caspase 1 can cleave 
the pro-inflammatory cytokines IL-1 and IL-18 to allow secretion, or result in pyroptosis. 
The use of different NAIPs as sensors for different ligands as occurs in the NLRC4 
inflammasome complex may apply to other inflammasomes, but remains to be explored 
(Broz and Monack, 2013). 
While the inflammatory effects of TLR sensing of conserved microbial patterns are 
typically studied as a single interaction, it has been described for some inflammasomes 
that NLR sensing of cellular damage is not sufficient on its own to result in pro-
inflammatory effects, instead requiring a priming signal from a toll agonist (Latz et al., 
2013). This may be due to a requirement for toll-mediated upregulation of transcription 
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of the unprocessed form of inflammatory cytokines that can then be processed by NLR-
induced caspases. Together, these pathways allow a rapid inflammatory response to be 
initiated upon recognition of generic indicators of potential danger. 
Later, the concepts of “innate-like” T cell subsets and non-specific activation of 
conventional T cells will be addressed as innate immune functions in adaptive immune 
cells. There is also evidence of T cells responding directly to PRR signaling, a 
mechanism we will not explore in any detail here simply because it does not appear to be 
involved in the pathways we have studied (Reynolds and Dong, 2013). Further, it is 
important to note that the term “non-specific” is itself somewhat misleading, as most 
innate immune receptors recognize specific ligands, these ligands simply aren’t specific 
to a single pathogen (Lanier, 2013). Overall, it seems the innate immune response has 
come to mean any rapid immune response not attributable to direct recognition of a 
rearranged lymphocyte receptor. While this makes categorization of an adaptive response 
simple, it disproportionately groups many complex and diverse pathways under an ill-
defined umbrella. As we begin to understand these innate and “innate-like” pathways 
better we are likely to gain an appreciation for their critical roles throughout the immune 
response.  
CD4 T cell development and priming 
As mentioned in the overview, adaptive immune responses develop to recognize a broad 
range of very specific antigens, rather than a small set of conserved patterns. This 
development of specificity relies on RAG-mediated recombination of the recognition 
sequences in the lymphocyte receptors of both B and T cells. For T cells, these initial 
development stages take place in the thymus, at which stage these T cells are also called 
‘thymocytes’. In brief, thymocytes enter the thymus as double-negative for both the CD4 
and CD8 co-receptors, with germline encoded TCR sequences. Genes for the γ, δ, and β 
TCR arms rearrange first by RAG mediated splicing and recombination of their variable 
regions. This results in either a strong Erk signal through a completed γδ TCR, resulting 
in development of a γδ T cell (discussed later), or a weak Erk signal through a pre-TCR 
complex of rearranged β-chain coupled to a surrogate, un-rearranged pre-TCR α chain. 
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Commitment to the αβ T cell lineage results in α chain rearrangement. 
Rearrangement of the TCR specificity is designed to provide recognition to a wide array 
of antigens. However, this random process also has the potential to result in T cells that 
either cannot interact with the MHC on which antigens will be presented, or T cells that 
will recognize and react to self-peptides, resulting in autoimmunity. These problems are 
dealt with by positive and negative selection, respectively. Thymocytes upregulate both 
CD4 and CD8, becoming double-positive (DP), express low levels of TCR, and require 
positive selection by an interaction with an MHC. This interaction will then inform 
expression of the transcription factor ThPOK, which commits thymocytes to the CD4 
lineage and represses Runx3, a transcription factor required for the CD8 lineage and 
cytolytic capacity (Cheroutre and Husain, 2013). At this stage T cells may also express 
Foxp3, thus committing to the natural regulatory T cell (nTreg) lineage, as opposed to the 
induced Treg (iTreg) subset of CD4 T cells that can differentiate in the periphery 
(discussed in the next section). Negative selection, on the other hand, occurs when a 
thymocyte is able to interact too strongly with a self antigen, and results in apoptosis. A 
thymocyte that successfully passes positive and negative selection will then leave the 
thymus, trafficking to peripheral lymph tissues as a naïve T cell. 
Conventional CD4 T cell activation is initiated when a naïve CD4 T cell encounters an 
antigen presenting cell (APC) within secondary lymphoid tissue, such as lymph nodes or 
spleen. This APC may be a dendritic cell (DC) that has encountered and taken up antigen 
in the periphery, including sites of infection, or more likely a circulating DC that has 
encountered a peripheral DC and ‘acquired’ antigen (Reis e Sousa, 2006). Antigen 
sampling by DCs occurs in the periphery constitutively, and circulation within the 
lymphatics is continuous, regardless of infection or inflammation. Thus, it is critical that 
T cells be able to distinguish between the self peptides typically collected by the DCs, 
and peptides collected from a potentially harmful source. Since DCs collect the antigens 
they present somewhat indiscriminately and display many of the PRRs mentioned in the 
last section that allow them to recognize danger, they are a key component of the innate 
immune response. However, their ability to patrol the periphery and then inform T cells 
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of the presence of both inflammation and particular antigens makes these cells critical to 
the initiation of adaptive immunity as well. In this way, DCs are the first key link 
between innate and adaptive immune responses.  
An APC first binds to a T cell by a weak interaction of cell-adhesion molecules, 
particularly the binding of ICAM-1 on the APC to LFA-1 on the T cell, and this 
interaction is usually non-productive. However, if the APC has engulfed and processed 
antigen, peptide will be presented on the cell surface within the MHC. Occasionally, the 
T cell receptor (TCR) will recognize the peptide presented in the MHC during these 
casual encounters and form either a stable interaction as a synapse, or a transient 
interaction, known as a kinapse (Dustin, 2008). This antigen-specific, or cognate antigen, 
interaction is known as signal 1 of T cell activation, and is illustrated in Figure A-2. 
While CD4 T cells interact with peptide MHC-II complexes presented on APCs, it is 
important to remember that CD8 TCRs recognize peptide on MHC-I instead, and that 
most cells have the ability to present MHC-I. The specific TCR:MHC interaction, while 
required, is not sufficient to induce differentiation or effector functions of the T cell on its 
own.    
In addition, evidence has shown that the nature of this initial TCR:MHC interaction can 
have significant downstream effects on the differentiation pathway (Gottschalk et al., 
2010; Turner et al., 2009), effector capacity, response to stimulation, and memory 
formation of T cells that occurs after this initial priming event. In particular, studies have 
examined the influence of the strength of this interaction (Moran et al., 2011; Zehn et al., 
2014), the duration (Miskov-Zivanov et al., 2013; Yarke et al., 2008), the number of 
successive TCR:MHC interactions (Celli et al., 2005; Moreau and Bousso, 2014), the 
effects of antigen concentration, and the role of inflammation and other stimuli on the 
nature of this interaction (Malherbe et al., 2008; Zehn et al., 2014).  
During this initial interaction, the naïve T cell needs to encounter additional cell-to-cell 
signals, called costimulatory signals, which serve as a second signal to promote naïve T 
cell activation. A naive T cell that receives only this first TCR signal, but not 
costimulation, will undergo anergy or deletion as a mechanism of peripheral self-
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tolerance. Anergic T cells are generally unable to become activated upon subsequent 
TCR:MHC interactions, even in the presence of co-stimulation. This form of tolerance is 
crucial to preventing autoimmune responses from T cells that either escaped negative 
selection, or for self-ligands that were not able to be presented in the thymus during T 
cell development.  
Costimulatory signals are believed to usually come from the same APC that initially 
presented antigen to the T cell, but this requires that the APC itself be activated, which 
results in the upregulation of the necessary interacting molecules on the APC. In the 
absence of disease DCs generally arrive in the lymph tissue in an unactivated state. In the 
context of infections, these DCs become activated by the innate inflammatory signals and 
conserved microbial patterns present at the sites of infection where the foreign antigen is 
collected. Activation of DCs, also sometimes referred to as ‘licensing’ or ‘maturation’, 
allows these cells to upregulate many of the surface molecules and chemokines required 
for a productive interaction with T cells, including increased MHC and LFA in addition 
to co-stimulatory molecules. (Reis e Sousa, 2006). Most often the activated APC 
upregulates B7.1 and B7.2 (also known as CD80 and CD86) to provide costimulation by 
interacting with CD28 on the T cell, but other activating and inhibitory co-stimulatory 
interactions can also occur (Chen and Flies, 2013). These first 2 signals allow T cells to 
survive and proliferate, but do not provide sufficient instructions for the T cells to 
determine a differentiation pathway. For this to occur a third signal is required, as shown 
in Figure A-3. This signal is typically believed to be a cytokine secreted by the same 
interacting APC as a result of its own activation, but potentially any cytokine present in 
the inflammatory milieu in sufficient quantity (Cui et al., 2009).  
CD4 T helper cell subset differentiation 
A number of cytokines are capable of causing differentiation, and thus delivering the 3rd 
and final signal for T cell activation. For CD4 T cells, different cytokines or 
combinations of cytokines will influence a different differentiation pathway, leading to 
different effector T cell subsets with distinct functions. While the differentiation resulting 
from signal 3 is sometimes simplified to suggest a solely cytokine-dependent decision 
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mechanism, it is of interest to note that costimulatory molecules, such as ICOS (Simpson 
et al., 2010), have been implicated in aspects of differentiation, effector function, cell 
survival, and memory formation. Further, as mentioned above, aspects of the initial 
TCR:MHC interaction can influence differentiation and effector function. These caveats 
suggest that this division of labor may not be as clear-cut as first appeared (Chen and 
Flies, 2013).  
For the purposes of this work, we will focus primarily on the differentiation of the Th1 
subset of CD4 T cells. When signal 1 and signal 2 are delivered to a naïve CD4 T cell, 
followed by interleukin-12 (IL-12), this 3rd signal causes differentiation toward a Th1 
phenotype. Further, Schulz et al demonstrated that interferon-gamma (IFN-γ) can 
upregulate both T-bet and the IL-12Rβ during activation, but that TCR signaling actually 
inhibits IL-12Rβ expression, therefore the timing of this 3rd signal is tightly controlled 
(Schulz et al., 2009).  However, while IFN-γ may promote the Th1 cell lineage by 
improving the capacity for IL-12 response, it is neither necessary nor sufficient on its 
own to cause Th1 differentiation (Haring and Harty, 2006; O'Donnell et al., 2014).  
While our work focuses on Th1 cell production of IFN-γ, numerous other CD4 T cell 
subsets have been identified, as outlined in Figure A-4. While Th1 cell differentiation 
requires IL-12, Th2 cells differentiate in response to IL-4, Tfh (T follicular helper) cells 
to IL-6 and IL-21, iTreg (induced T regulatory) cells to TGF-β and IL-2, and Th17 cells 
to a combination of TGF-β, IL-6, IL-21, and IL-23 (Lazarevic et al., 2013). Another, less 
understood, subset of CD4 are able to acquire the cytotoxic capacity typically associated 
with CD8 T cells (also called CTL, or cytotoxic lymphocytes), and are thus named CTL 
CD4. This differentiation is believed to result from very strong TCR signaling rather than 
a particular signal 3 cytokine, but this requires further investigation (Cheroutre and 
Husain, 2013).  
Each subset has a lineage defining transcription factor associated with its differentiation, 
but in fact each differentiation pathway results in the upregulation or suppression of 
many different transcription factors and cytokines. Briefly, Th2 differentiation is defined 
by GATA3, Tfh by BCL-6, iTreg by Foxp3, and Th17 by ROR-γt. CTL CD4 must 
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downregulate the thymic CD4 lineage determining transcription factor ThPOK and 
upregulate Runx3, typically expressed by CD8 T cells, in order to acquire cytolytic 
capacity (Cheroutre and Husain, 2013). These transcription factors allow expression of 
key effector cytokines for each subset, shown in Figure A-4. (Geginat et al., 2013; 
Lazarevic et al., 2013). 
Th1 differentiation is characterized by the upregulation of the hallmark transcription 
factor T-bet, but involves the upregulation or suppression of many other genes as well. In 
particular, T-bet is known to suppress the transcription factors required for other T helper 
lineages by epigenetic modification (Lazarevic et al., 2013). These changes allow 
production of effector cytokines such as interferon-gamma (IFN-γ), tumor necrosis 
factor- alpha (TNF-α), and IL-2, as well as inhibiting the responses typical of other CD4 
T cell subsets, such as IL-10 or IL-4 production. Although this differentiation signal is 
required to complete activation, there is now considerable evidence that these 
differentiation pathways are not permanent, a capacity known as plasticity. 
The process of differentiation during the initial priming events drastically alters the T 
cell, affecting not only cascades of transcription factors but also miRNA regulation and 
the epigenetic signature (Sallusto and Monticelli, 2013). All of these changes are geared 
toward allowing the T cell to specialize and more rapidly respond when called into 
action. Despite this, T cell effector function after activation requires continued regulation, 
both to prevent unnecessary inflammation at off-target locations and to conserve 
resources. Thus, both effector and memory T cells must continuously walk a fine line 
between a rapid and a harmful response. The secondary signals that elicit effector 
functions after Th1 cell activation will be the subject of a later section.     
Differences between CD4 and CD8 T cell activation 
When considering any T cell intrinsic mechanism or function it is important to remember 
that what is true for CD4 T cells is not always the case for CD8 T cells, and vice versa. 
This is an important distinction when considering what is or is not ‘known’ for a given T 
cell response. To complicate this issue, often these differences are context dependent, 
with different infections or inflammatory circumstances altering the relative response of 
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each population differently. While signal 1 in CD4 T cells occurs in response to 
extracellular or phagosomal antigen that has been engulfed and presented by MHC-II on 
APCs, CD8 T cell signal 1 is mediated by MHC-I presented antigen derived from 
cytosolic processing and presented on the surface of nearly all cell types. The result is a 
strong cytotoxic CD8 response to infections which occur inside of cells, except those 
contained within vesicles, which trigger MHC-II presentation and thereby CD4 
responses. This allows for a partial division of labor between T cell lineages, although 
some critical functions overlap or provide redundancy, such as IFN-γ production. 
The 3rd signal in CD8 T cell priming is not usually thought of in terms of differentiation 
of particular subsets with distinct functions, as seen for CD4, although functional subsets 
have been described. Termed Tc1, Tc2, and Tc17 in reference to their Th counterparts, 
these cells are found in relatively low frequency under normal circumstances, and the 
mechanisms driving the development of these alternative CD8 T cells remain poorly 
understood (Geginat et al., 2013). Signal 3 was initially identified in CD4 and CD8 T 
cells simply as the inflammatory cytokine(s) required to induce proliferation and 
differentiation to effector capacity (Curtsinger et al., 1999). Type I interferons and IL-12 
have both extensively been shown to result in the survival, expansion, and differentiation 
of CD8 T cells, and are critical for the conventionally described CD8 T cell effector 
responses, including cytolytic activity and IFN-γ production. (Curtsinger et al., 1999; 
Haring et al., 2006; Mescher et al., 2006; Pham et al., 2011). 
Additional differences between CD4 and CD8 T cell activation include, but are not 
limited to: a shorter required duration of antigenic stimulation in CD8 T cells (Celli et al., 
2005; Obst et al., 2005; van Stipdonk et al., 2001), different transcriptional regulation, 
including partial redundancy for the transcription factors T-bet and Eomes in IFN-γ 
production in CD8, but not CD4 (Lazarevic et al., 2013), and differences in cellular 
trafficking and antigen surveillance (Mandl et al., 2012). Further, evidence suggests that 
CD4 T cells can help to initiate CD8 T cell priming (Beuneu et al., 2006; Castellino et al., 
2006), and may be required for optimal CD8 memory formation, a regulatory interaction 
that argues against mechanistic redundancy in the activation process. Thus, while T cells 
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have evolved to share many similar pathways, CD4 and CD8 T cells are distinct cell 
types with different functions and rules to govern them.  
Non-cognate activation of conventional T cells 
While the strict rules governing conventional T cell activation are important to prevent 
unnecessary inflammation, under severe circumstances, such as occur during a rapidly 
dividing or systemic infection, the immune response must engage in a carefully-
controlled race in which the conventional rules become a hindrance to achieving the 
necessary strength and rapidity of the effector response. For this reason, it may not be 
surprising that non-cognate interactions with conventional T cells have also been 
described. This is often referred to as “bystander activation” (Bou Ghanem and D'Orazio, 
2011; Kamath et al., 2005; Lertmemongkolchai et al., 2001; McNally and Welsh, 2002), 
seemingly in reference to the idea that these are cells which happen to be in proximity to 
the necessary stimuli, perhaps intended for other cognate-specific cells engaged in direct 
interactions, thus making the non-cognate cell an unintended ‘bystander’ of the 
conventional response. However, it is equally possible that this bystander response is not 
incidental, but an integral functional capacity of T cells to recognize extreme stress.  
In considering sources of activation for T cells, it is important to recognize that the 
ambiguous use of the word "activation" in reference to interactions encountered by T 
cells is a source of confusion in the literature. Activation is sometimes used to describe: 
1) the initial process undergone by naive T cells in secondary lymphoid organs that 
results in proliferation and emigration to sites of infection, as described above 2) the 
secondary stimulation of previously activated effector T cells that occurs upon arrival at 
sites of infection, which will be explored in more detail in the next section and 3) the re-
activation of resting memory T cells, which will be discussed later. Figure A-5 looks at 
each of these circumstances and compares conventional T cell interactions to bystander 
or non-cognate and innate-like T cell interactions. While the word activation has been 
applied to each circumstance, significant differences exist between each of these types of 
T cell interaction. Further exploration of the inherent requirements of each type of T cell 
interaction requires a more detailed understanding of how the existing evidence applies to 
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each circumstance separately.  
The earliest descriptions of bystander activation focus on cytokine or innate stimuli 
inducing T cell proliferation in the absence of antigen (Kamath et al., 2005; McNally and 
Welsh, 2002; Tough et al., 1996). However, most of this work was done in viral infection 
models, focuses on CD8 T cells, and does not differentiate between naïve and previously 
activated T cells. Further, these data must be interpreted with caution, since cytokine-
induced proliferation may not always lead to an effector T cell state, and especially given 
the evidence that these same signals can induce apoptosis (McNally and Welsh, 2002). 
Transient expression of the early activation marker CD69 was observed in naïve CD8 
after Type I IFN stimulation, but this activation was not maintained nor was it shown to 
induce effector functional capacity (Kamath et al., 2005).  
There is also considerable work describing elicitation of effector functions from CD8 T 
cells by non-cognate stimuli, also often referred to as bystander activation or stimulation 
(Freeman et al., 2012; Lertmemongkolchai et al., 2001; Raué et al., 2004). However, it is 
important to note that this work generally describes stimulation of previously activated T 
cells, or makes no distinction between activated and naive T cells, thus this is not 
activation in the sense of initial T cell priming. Bystander stimulation of effector and 
memory T cells will be discussed in more detail in a later section, and the intrinsic 
differences between naive and activated T cells was discussed briefly already.  
Even less evidence for TCR-independent stimulation exists specific to CD4 T cells, and 
most show that bystander responses occur only in previously activated or memory CD4 T 
cells (Bangs et al., 2009; Chapman et al., 2005; Di Genova et al., 2010). There is, 
however, limited in vitro data showing that very high doses of IL-2 can make naïve CD4 
T cells responsive to IL-12 or IL-18 without TCR signaling (Chakir et al., 2003). 
Considering these distinctions, as well as the inability of many of these studies to rule out 
innate-like populations that were not yet identified at the time the studies were conducted, 
the question of whether naive T cells can be primed in a non-cognate manner under 
sufficient inflammatory stimulation, and whether these cells would be functional as 
effectors in vivo, lacks a definitive answer. The work described herein does not attempt to 
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address this question, but rather examines non-cognate secondary stimulation at sites of 
infection, which for clarity we will not refer to as activation. 
Secondary stimulation of T cells 
Conventional T cell activation in secondary lymphoid tissues, as outlined above, results 
in trafficking of activated T cells to the sites of infection, where their effector functions 
are needed. A T cell that has been activated is now ready to respond rapidly upon 
additional stimulation, but does not constitutively secrete cytokines. At the site of 
infection, an activated T cell may encounter additional cognate antigen presented by 
APCs there, and this second specific interaction will trigger a robust effector response. 
Unlike the initial activation process, this antigen-specific interaction alone is sufficient to 
induce cytokine production, because of the T cell’s activated state (Honda et al., 2014). 
Several works in the past five years have examined this requirement for additional 
stimulation at the site of infection, focusing on the necessity of local cognate antigen 
presentation to induce effector responses. Particularly, McLachlan et al showed in vivo 
that T cells activated in response to an antigen and adjuvant will produce effector 
cytokines when antigen is readministered in one ear, but do not produce cytokines to 
irrelevant antigen given in the other ear. Further, the effector response can be halted by 
blocking the TCR interaction with the antigen. (Egen et al., 2011; McLachlan et al., 
2009).While these studies demonstrate that T cells do not arrive in the periphery still 
producing cytokines from their initial activation, and that secondary antigen interactions 
are sufficient to promote effector responses, they do not conclusively rule out other 
mechanisms for effector T cell stimulation. In addition, the T cells are activated by an 
antigen and adjuvant combination, which models the low inflammatory conditions of a 
vaccine rather than the highly inflammatory environment of an infection. The impact of 
inflammation on T cell programming at every stage is still an area poorly understood, but 
it is possible that as we learn more about these interactions we will uncover some of the 
pathways that have so long separated vaccine efficacy from the immunological memory 
that follows infection. 
For a number of reasons discussed later, an activated T cell may never encounter its 
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cognate antigen at the site of infection. In fact, Egen et al demonstrate that T cells in 
mycobacterial granulomas have limited encounter with their cognate antigen, and suggest 
that this is the reason for their limited production of effector cytokines. They further 
show that providing additional antigen leads to increased production of IFN-γ, and 
deduce that antigen presentation is a limiting factor within granulomas that prevents T 
cell activation (Egen et al., 2011). Again, while this data provides evidence that antigen at 
sites of infection can elicit T cell production of effector cytokines, it does not rule out 
other mechanisms of T cell stimulation. In fact, as mentioned earlier, administration of T 
cell stimulatory cytokines or IFN-γ can resolve granulomas. Thus, if antigen presentation 
is limited within granulomas, it stands to reason that the known effects of these 
treatments may indeed be antigen-independent. 
Further, it has been shown that myeloid cells deficient for MHC II have higher 
mycobacterial loads than their MHC II- sufficient counterparts within the same host 
(Srivastava and Ernst, 2013). This suggests that the resolution of infection within these 
myeloid cells requires contact-dependent activation. However, as in the works mentioned 
above, this study cannot differentiate between the requirement for an initial cognate 
activation interaction and subsequent interactions, although in this case the signals in 
question are those to the infected cells, not the T cells. Thus, it is possible that myeloid 
cells, once activated in a contact-dependent manner, can then respond to CD4 T cell 
cytokine production at the site of infection. Intravital imaging in mice during Leishmania 
infection supports this idea, showing that macrophages within an 80 micrometer radius of 
CD4 T cells producing IFN-γ contained higher levels of iNOS (inducible nitric oxide 
synthase) without requiring direct contact with the T cells (Muller et al., 2012). However, 
it is also important to note that in the latter study a significant difference in pathogen 
burden was not observed in MHC II- deficient phagocytes, supporting the suggestion of 
Srivastava and Ernst that different pathogens may elicit different response requirements. 
Taken together, the above studies demonstrate a role for cognate-specific interactions, but 
do not rule out a role for non-cognate interactions. 
Additionally, when time is a limiting factor, waiting for repeated APC: T cell interactions 
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to result in a productive encounter in a chaotic inflammatory environment may not be 
practical. For these reasons, a non-cognate mechanism of stimulation for T cells that have 
already been activated in a conventional, cognate-specific manner is both logical and 
probable. As detailed in a separate section below, this response is well recognized for 
many types of lymphocytes described as “innate-like”, but for conventional T cells the 
concept of an innate response is not well described as such. These cell sets and their 
responses to different stimuli are outlined in Figure A-5. 
As mentioned earlier, much of the literature pertaining to “bystander activation” 
describes responses of previously activated T cells, particularly CD8 T cells due to the 
predominant use of viral infections within this area of study. Much of this work has 
focused on the proliferative capacity of T cells, largely in response to common gamma 
chain cytokines or Type I IFN, which is an important point in the early amplification of 
an effector response . However, it is also important to define whether these proliferating 
cells actually go on to be functional effectors in an in vivo setting, and to consider the rate 
of apoptosis alongside proliferation (Curtsinger et al., 2003; McNally and Welsh, 2002). 
The work herein will focus on bystander stimulation during a later phase of the effector 
response: the elicitation of the effector functions. In CD8 T cells this can mean a variety 
of things, from secretion of effector cytokines, to the production of granzyme and 
cytolytic functions. For CD4 Th1 cells, elicitation of the effector response is determined 
by production of the effector cytokines IFN-γ, TNF-α, and IL-2. 
As discussed above, T cells are believed to secrete IFN-γ at the site of infection while 
directly engaged by an infected APC, allowing this cytokine to be released in a targeted 
manner, thus containing the inflammatory effects at the synapse. In fact, in vitro evidence 
shows that secretion of certain cytokines like IFN-γ, but not others like TNF-α, is 
polarized toward the TCR/ MHC synapse (Huse et al., 2006). However, a large body of 
in vitro literature now supports the idea that a previously activated T cell can also be 
stimulated without direct cognate-interaction in the presence of sufficient inflammatory 
signals. In particular, IL-12 and IL-18 are known to stimulate IFN-γ production, and 
indeed IL-18 was originally called interferon-gamma inducing factor (IGIF). 
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Nonetheless, a multitude of cytokines in various combinations have now been shown to 
elicit IFN-γ production from T cells. Most of this literature looks at CD8 T cells and in 
vitro stimulations (Berg and Forman, 2006; Freeman et al., 2012). Alternatively, previous 
work in our laboratory explored the role of IL-18 in LPS stimulation of Th1 cells 
(Srinivasan et al., 2007). While all of this work together suggests the possibility of a 
mechanism wherein T cells are innately stimulated in order to quickly amplify the 
adaptive response, an exact mechanism and role for this innate-like CD4 Th1 response 
has not been well characterized. 
Innate stimulation of memory versus effector T cells 
Thus far, we have discussed how naïve CD4 T cells develop in the thymus, travel to 
secondary lymphoid tissue, encounter APCs there, and require 3 specific signals for 
conventional activation. After a naïve CD4 T cell 1) recognizes a specific peptide 
sequence presented on MHC-II with its TCR, 2) receives co-stimulatory signals such as 
the CD28 interaction with CD80/86, and 3) receives IL-12 signaling this CD4 T cell will 
proliferate and differentiate into a Th1 cell. These cells upregulate surface markers and 
chemokine receptors that allow them to leave the secondary lymphoid tissues and travel 
to sites of infection, as well as altering their expression profiles for a myriad of 
transcription factors and cytokines. These changes render the effector cell capable of 
rapid response upon secondary stimulation at the site of infection, limiting the production 
of cytokines to the locations they are most needed. While this secondary stimulation is 
usually thought to be TCR-dependent, there is evidence for a TCR-independent 
mechanism as well. 
This expansion of specific effector Th1 cells typically takes a few days, and in prolonged 
infections like Salmonella this T cell response can take a few weeks to reach the peak of 
expansion. During this time T cells are responding to a complex network of signals: IL-7 
to survive, IL-2 to proliferate, pro-inflammatory cytokines to strengthen responses, anti-
inflammatory cytokines to dampen responses, and potentially TCR signals. The 
combination of these encounters does more than just stimulate T cells to produce effector 
cytokines- it establishes their fate. While T cell responses are critical to pathogen 
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clearance in many cases, they are also highly toxic. For this reason, most T cells will 
ultimately be instructed to die. After the peak of expansion T cells undergo a contraction 
phase in which most T cells receive apoptotic signals.  
However, some T cells will receive just the right combination of stimuli and survival 
signals to transition from an ‘armed and ready’ effector state to a quiescent memory state. 
CD4 T cells can actually exist in a number of different memory states, which may 
ultimately effect their longevity, the areas in which they circulate, and the requirements 
for re-activation. The best described examples of CD4 memory subsets are the central 
versus effector memory T cells, which circulate in lymphoid tissue or non-lymphoid 
tissue, respectively. CD8 T cells are also believed to form these subsets, as well as 
memory populations called short-lived effector cells (SLECs) or memory precursor 
effector cells (MPECs) whose formation depends heavily on the inflammatory signals 
received, but which have not been described for CD4 T cells. Memory T cells are an 
important component of the rapid response to re-challenge with previously encountered 
pathogens because of their lowered activation threshold, pre-differentiated state, and 
extensive modifications that allow for rapid relay of the signals needed to elicit effector 
function. Understanding how these T cells are formed and are able to respond is 
especially crucial to vaccine design. 
Further complicating the issue of non-cognate T cell stimulation is the lack of 
understanding as to how this response differs between effector and memory T cell 
populations, or how this response would impact memory T cell formation. The dramatic 
changes undergone by T cells in the transition from naïve to activated state, discussed 
briefly earlier, have been well studied. However, of equal importance and less clarity is 
the question of the cell-intrinsic changes that differentiate effector and memory T cell 
populations, how these populations are generated, and how these differences impact 
response to stimulation. Particularly, while recent work has begun to address these 
questions in CD8, very little is known about the response threshold of memory CD4 T 
cells (Lazarevic et al., 2013). Given that much of the work for the CD8 response to 
inflammation is in the context of the fate decision signals that lead CD8 to become either 
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SLECs or MPECs, whereas such populations have not been described in CD4 memory T 
cells, it will be important to examine the effects of non-cognate stimulation of effector 
CD4 on memory formation separately from studies of CD8 T cells (Plumlee et al., 2013). 
Further, the mechanisms and requirements for non-cognate stimulation of CD4 memory 
T cells and CD8 memory T cells is likely to differ, as are the specific signals required to 
stimulate the different CD4 memory subsets, whether effector versus central memory, or 
Th1 versus Th17 primed. While CD4 memory T cells retain transcriptional memory of 
priming, elicitation of their responses may also be susceptible to the plasticity seen in 
effector CD4 T cells, a fact which is likely to play an important role in the effects seen by 
non-cognate restimulation of memory CD4 (Lazarevic et al., 2013; Pepper and Jenkins, 
2011).  
Non-conventional T cells and ILCs 
Although conventional T cell activation occurs in the highly regulated, antigen-specific 
manner described above, there are a number of exceptions to these rules. In particular, a 
number of cell subsets have been described that have overlapping surface markers, 
developmental lineages, transcription factor profiles, or effector functions to conventional 
T cell subsets, but which respond in a non-conventional manner (Lanier, 2013). These 
cells are often thought of as innate-like cells with adaptive-like functions that can provide 
critical assistance in the early immune response. Examples include natural killer T (NKT) 
cells, mucosal-associated invariant T (MAIT) cells, γδ T cells, and innate lymphoid cells 
(ILCs), but this list will undoubtedly continue to expand as the sensitivity of cell 
detection techniques continues to improve.  
ILCs are a rapidly expanding group of cells defined predominantly by their lack of 
lymphocyte antigen receptors (TCR/BCR) or lineage-specific markers (Lanier, 2013). 
Recently, a uniform nomenclature for ILCs was proposed that divides the various cells 
into 3 main groups. Much like the CD4 T helper subsets, Group 1 ILCs can be 
characterized by the expression of T-bet and IFN-γ, Group 2 express GATA3, and Group 
3 express ROR-γt and produce IL-17 or IL-22. (Spits et al., 2013). Most ILCs require IL-
7R signaling and express the surface marker CD90 and the transcription factor ID2, 
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although it has been proposed in mice that IL-7 may inhibit transition of ILC3 to ILC1 
(Walker et al., 2013). Given the focus of this work on Th1 and IFN-γ production, further 
elaboration will center on the Group 1 ILC subset.  
Natural killer (NK) cells have been included within this nomenclature as a Group 1 ILC, 
alongside ILC1. While NK cells have been very well described as an early source of IFN-
γ and TNF-α, in addition to their cytotoxic functions, very little is known about ILC1. 
Although there is evidence that they develop from ILC3s after IL-12 stimulation, it was 
recently shown that ILC1 can also develop independently from a common innate 
lymphoid progenitor (Klose et al., 2014). However, whether they arise separately or as a 
consequence of functional plasticity, it remains that there is a group of T-bet+ ILCs which 
can respond to IL-12 and IL-18 signals to produce IFN-γ, but which are not NK cells and 
do not exhibit cytotoxicity (Spits et al., 2013; Walker et al., 2013). As a whole, the early 
innate effector responses of the Group 1 ILCs during intracellular infections play a key 
role in host protection, inflammation and initiation of adaptive responses. 
While ILCs lack a TCR, several cell types express unique TCRs that allow for a non-
conventional response, known collectively as “innate-like T cells” due to their ability to 
respond rapidly to innate stimulation. Among these innate-like T cells, one common 
method allowing for a non-cognate-antigen response is an invariant or semi-invariant 
TCR. While conventional TCRs undergo RAG (recombination activating gene) 
dependent rearrangement of their α and β chains during development in the thymus to 
allow for a broader repertoire with improved specificity, some innate-like cell 
populations possess TCRs with single α-chain and restricted β-chain specificities. 
Particular examples of cells with these alternative TCRs include invariant NKT cells 
(iNKT) and MAIT cells (Lanier, 2013). 
NKT cells are perhaps the best described of these innate-like T cell subsets. NKT cells 
are innate-like T cells in the sense that they develop in the thymus and express a TCR, 
but they also express NK1.1 and several innate activating or inhibtory receptors typically 
found on NK cells (Brennan et al., 2013). Two types of NKT cells exist: NKT I are the 
well-described, invariant NKT cells known to respond to lipids and especially with high 
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affinity to α-galactosylceramide presented by the MHC-related molecule CD1d, while 
NKT II are less studied to date, but have a diverse TCR repertoire and fail to respond to 
α-galactosylceramide (Gapin et al., 2013). While iNKT can be activated by CD1d 
presentation of foreign lipid antigens, they may also be activated by CD1d presentation of 
lipid self-antigens and require inflammatory cytokine signals, allowing for more rapid 
and innate-like responses (Brennan et al., 2013; Brigl et al., 2011; Gapin et al., 2013). 
Another semi-invariant T cell population are the recently described MAIT cells, 
characterized by their localization to mucosal tissue and their recognition of the MHC-
related molecule, MR1, which binds the metabolites of B vitamins generated by bacteria 
and fungi (Lanier, 2013). MAIT cells develop and are pre-programmed in the thymus, but 
quickly acquire an activated phenotype in the periphery. There is now evidence to 
suggest that this activation occurs in response to microbiota; in particular, the observation 
that germ-free mice have diminished numbers of MAIT cells, which can be recovered 
upon monoculture reconstitution with many bacteria or yeast, but not Enterococcus 
faecalis, which lacks the riboflavin metabolic pathway. Unlike NKT, they seem to 
respond predominantly to TCR ligation and do not require cytokine stimulation to elicit 
effector functions, which consist mostly of IFN-γ and TNF-α, although they can also 
express IL-17 (Gold and Lewinsohn, 2013; Le Bourhis et al., 2013)  
γδ T cells are a unique exception, in that they possess recombined TCRs, but can respond 
in a rapid, innate-like manner to inflammatory cytokines. Thus, these T cells are 
technically a component of the adaptive immune response, but are often discussed in the 
context of early innate responses (Vantourout and Hayday, 2013). Differentiation 
programming of γδ T cells occurs during thymic development, determining either an 
IFN-γ, IL-17, or IL-4 producing phenotype (Narayan et al., 2012), but peripheral 
activation is still required before effector functions can be elicited. The relative 
contributions of TCR, costimulation and cytokine signals to this activation still seem to 
be a matter of some debate, and may be partially dependent on the subset, but whatever 
the mechanism these cells respond far more rapidly than their αβ T cell counterparts 
(Katsikis et al.; Vantourout and Hayday, 2013). 
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All of these innate-like T cells (iNKT, MAIT, and γδT), although possessing different 
TCRs and recognizing different antigen repertoires, share some common features. For 
one thing, in each cell type the ability to generate or maintain immunological memory is 
poorly defined, as are the required signals for survival and proliferation (Lanier, 2013). 
The observation that MAIT cells in vitro do not proliferate in response to the 
conventional common-γ chain cytokine signals, but do proliferate somewhat in response 
to IL-1 family cytokines, highlights the likelihood of differences in these pathways 
between conventional T cells and their innate-like counterparts, and the need to elaborate 
these mechanisms further (Le Bourhis et al., 2013).  
For both iNKT and γδT cells functional subsets have now been described analogous to 
the CD4 T helper subsets (Brennan et al., 2013; Narayan et al., 2012), although unlike 
CD4 T cells these subsets are pre-determined during development in the thymus. The 
Th1-like subsets that are of greatest interest to this work respond strongly to IL-12 to 
produce IFN-γ, and utilize the transcription factor T-bet with some similarities to Th1 
(Lazarevic et al., 2013). Although subsets have not yet been defined as such for MAIT 
cells, and they typically respond to IL-12 to produce IFN-γ in a T-bet-dependent manner, 
they also express ROR-γt and can express IL-17 and IL-22 under appropriate stimulation. 
Further, there is now some evidence for an immunoregulatory function of MAIT cells. 
Thus, whether MAIT cells have functional subsets or are simply functionally 
promiscuous remains to be determined (Gold and Lewinsohn, 2013; Le Bourhis et al., 
2013).  
In further similarity, each is described as “innate-like” due to an ability to rapidly respond 
to innate stimulation- that is, they respond to the inflammatory cytokines that result from 
innate stimuli. However, for each cell subset the specific requirements of initial priming, 
and in particular whether this priming can occur without any peripheral TCR stimulation, 
is still a matter of debate within their respective fields. While earlier literature suggested 
that these cells respond rapidly because they are able to respond to cytokine alone, other 
work shows that these cells require TCR interactions (Ribot and Silva-Santos, 2013), and 
for iNKT at least this requirement can be met by self-antigens under inflammatory 
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conditions to allow more rapid responses (Brennan et al., 2013; Brigl et al., 2011; Gapin 
et al., 2013). Herein, we make an argument that conventional αβ T cells can also respond 
rapidly to inflammatory cytokines in an innate-like manner once they have been primed, 
suggesting a conservation of these stimulatory mechanisms between conventional and 
innate-like T cells, and highlighting the need for a better understanding of the activation 
requirements of non-conventional T cells. 
Relevance of innate T cell stimulation 
Finally, in considering the mechanisms that might allow T cells to respond in a non-
cognate manner, it is important to address the reasons it might be beneficial for a 
conventional T cell to have retained these functions during evolution. In other words, 
why might a T cell need to respond to a non-TCR signal? Further, why should a T cell 
require a TCR signal at all? What is lost and what is gained when a T cell bypasses the 
strict antigen-specific regulation of the TCR?  
The strong inflammatory capacity of the T cell response is mediated in part by a massive 
capacity for proliferation and cytokine (or other effector) output, but this strength comes 
at the cost of a severe inflammatory state. Excess inflammation can itself cause cellular 
damage and can lead to sepsis and shock. For this reason, the strongest responses are 
regulated to occur only in the direst circumstances. In T cells, one way to localize the 
effector response is to require direct contact with antigen, thus ensuring the cytokine is 
only made when and where it is needed. Most of the time this is a logical checkpoint, but 
what if direct contact with the antigen at the site of infection either cannot occur, or is too 
limited to facilitate the magnitude required, as discussed earlier? 
In fact, many pathogens use this strategy to evade the immune system. Salmonella, for 
example, quickly downregulates many of the antigens that would be recognized by the 
early T cell response (Lee et al., 2012). The result is large numbers of T cells at the site of 
early infection primed to respond to antigens that do not exist at the site of infection. 
Further, while the lymph tissue is designed to streamline movement of APCs and T cells 
in such a way as to facilitate potential interactions for initial activation, most sites of 
infection are inflamed and chaotic battlegrounds, wherein finding an APC presenting the 
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appropriate antigen will, at best, take time that the host may not have (Masopust and 
Schenkel, 2013; Moreau and Bousso, 2014). 
In addition to immune evasion strategies that involve limiting antigens, many strategies 
of limiting the MHC molecules or their ability to present antigens have been described, 
with a similar outcome- T cells activated against pathogens that they cannot re-encounter 
(Bueno et al., 2012; Cheminay et al., 2005; Lapaque et al., 2009). Further, evidence has 
shown the ability of Salmonella to downregulate TCR expression on T cells, which 
would impair initial priming, but could also prevent cognate secondary restimulation (van 
der Velden et al., 2008). Many evasion mechanisms of both innate and adaptive 
immunity have been described for Salmonella, as just one example demonstrating an 
acquired capacity to evade the immune system at just about every turn (Fabrega and Vila, 
2013; Jantsch et al., 2011).  
Further, while work in the lab reasonably requires limiting variables, infection in nature 
is content to be as confusing as possible. Thus, it is unlikely that immune responses 
evolved with a design to combat only one infection at a time, given the selective pressure 
of many simultaneous infections. In fact, 50 years ago Mackaness described the 
bystander capacity of macrophages activated in response to one intracellular pathogen to 
lower the bacterial loads of a second intracellular pathogen (Mackaness, 1964). 
Bystander responses of innate immune cells during co-infection or polymicrobial 
infections have become well accepted because the mechanism of cross-reaction in a non-
specific response is easily explained. On the other hand, non-cognate T cell responses are 
often viewed as an abnormal occurrence, a breakdown in the specific regulatory 
capacities that keep these effector responses in check. However, we now know that a 
number of T cell types exist with the integral functional capacity to respond in a rapid 
“innate-like” manner, as detailed earlier. Given our current understanding of the 
mechanisms that govern these innate-like responses, it seems wholly feasible that not 
only are T cells capable of responding to antigen-non-specific signals of threats in a 
crisis, but that this capacity evolved as an important facet of their responsiveness and 
plays an important physiological role. 
 Introduction 
 32 
 
 
 
Figure A-2: TCR: MHC interactions on T cells 
The T cell receptor (TCR) on CD4 T cells recognizes peptide sequences presented on MHC-II by 
APCs. They are identified by the cell surface molecule CD4, which interacts with MHC-II to 
stabilize the TCR: MHC interaction, as shown above. CD8 T cells interact with peptide on MHC-
I, which is present on most cells, and this interaction is stabilized by the CD8 cell surface 
molecule. The inset shows the structure of the α:β TCR, which consists of rearranged α and β 
peptide recognition chains, a CD3 domain flanking each side, and internal ζ signaling chains. 
Both the CD3 and ζ chains contain signaling motifs known as ITAMs (immunoreceptor tyrosine-
based activation motifs) whose phosphorylation initiates the TCR signaling cascade. 
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Figure A-3: Priming of CD4 T cells requires 3 signals 
Conventional activation of naïve CD4 T cells requires 3 distinct signals. Signal 1: the TCR (T cell 
receptor) on the T cell must recognize a particular peptide sequence, processed within an APC 
(antigen presenting cell) and presented by MHC-II (Major Histocompatibility Complex- II) in 
mice. The CD4 co-receptor shown stabilizes the T cell interaction with MHC-II. Signal 2: 
activated DC (dendritic cells) upregulate the costimulatory molecules B7.1 and B7.2 (also called 
CD80 and CD86). CD28 on T cells recognize these costimulatory molecules as a second signal 
for activation. In the absence of costimulation T cells undergo anergy or death. Signal 3: the 
cytokine environment instructs the final stage of T cell priming by determining the differentiation 
pathway undergone by the activated T cell. These differentiation pathways are outlined in Figure 
A-4. 
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Figure A-4: Development and differentiation of CD4 T cells into helper subsets  
T cell lineage is determined in the thymus, where these T cells are referred to as thymocytes. 
During thymic development these thymocytes receive signals that will either reinforce expression 
of the transcription factor ThPOK and suppress Runx3, leading to the CD4 lineage, or lose 
ThPOK expression, allowing upregulation of Runx3 and CD8 lineage determination. Some of 
these CD4 T cells will upregulate FoxP3 in the thymus to become natural Tregs (nTregs), while 
most will migrate to secondary lymphoid tissues as naïve CD4 T cells. Naïve CD4 T cells are 
activated upon interaction with an APC, leading to a TCR:MHC interaction and co-stimulatory 
signals, as described in Figure A-3. These T cells then need a third cytokine signal to inform 
differentiation, shown above. The cytokines listed in the top of the blue inset instruct CD4 T cells 
to differentiate into the cell types listed below them, requiring upregulation of the lineage-
defining transcription factors shown in the boxes. The transcription factors then lead to 
production of the hallmark effector cytokines listed below the arrows, at the bottom of the blue 
inset. For example, IL-12 serves as a third signal to cause CD4 T cells to differentiate into Th1 
cells that upregulate T-bet and secrete IFN-γ, TNF-α, and IL-2, illustrated in dark blue. The 
cytokines leading to CTL differentiation are listed as a question mark because this cell type is 
only recently described and these signals are still poorly understood, but the current theory is that 
TCR signal strength may actually be the driver for differentiation of this subset.  
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Figure A-5: Elicitation of CD4 and ‘innate-like’ T cell effector functions 
T cell effector functions can result from interactions with APCs or cytokines at various stages. In 
the conventional T cell response (first column), naïve T cells are activated by direct interactions 
with APCs in the secondary lymphoid tissues, proliferate, migrate to sites of infection, and then 
are stimulated by secondary direct APC contact to produce effector cytokines. Some of these 
effector T cells will go on to become memory T cells. T central memory (TCM) cells circulate in 
secondary lymphoid tissues, and upon reactivation will once again proliferate and differentiate 
into effector cells. T effector memory (TEM) cells can either migrate in the periphery or be 
resident in tissue, and respond more rapidly than the TCM cells because upon reactivation they can 
secrete effector cytokines directly. The signals that result in the TEM or TCM fate decision are still 
unclear, as are the interactions required by each for reactivation, although it is presumed that 
reactivation occurs after direct interaction with an APC. 
Non-cognate stimulation (second column) occurs at sites of infection in T cells that have already 
undergone conventional activation in the secondary lymphoid tissues. Instead of being stimulated 
by secondary direct APC contact, these cells receive stimulatory signals from cytokines that 
induce IFN-γ production. Whether these cells go on to join the memory pool and how this 
different stimulation signal affects the fate decision of CD4 T cells is unknown. Although the 
initial priming signals for the different innate-like T cell populations vary and are still unclear in 
some cases, they include alternative activation mechanisms such as restricted TCRs or 
constitutive priming. Stimulation of effector responses at sites of infection in innate-like T cells is 
known to occur rapidly in response to cytokine stimulation, hence the name ‘innate-like’ T cells. 
However, it is possible that all T cells have the capacity, once activated, to respond rapidly to 
cytokine stimulation, and that what really separates these innate-like cell types are their unique 
priming mechanisms. 
Bystander activation is a term that has been used loosely to mean any TCR-independent T cell 
stimulatory interaction. In the last column, we focus on the idea of bystander activation as a 
mechanism to prime a CD4 T cell in a TCR-independent manner. While the effect of cytokines 
on naïve T cells have been studied at length in vitro, there is limited evidence that a naïve CD4 T 
cell can be activated by cytokine signals alone, and no evidence that TCR-independent activation 
can produce a fully functional effector T cell. 
 
 
 
 
Chapter 1: 
What triggers innate stimulation of Th1 cells? 
Figure 1-1: Innate ligands cause Th1 cells to produce IFN-γ 
Pathogens result in the production of PAMPs and DAMPs. These innate stimuli are known to 
elicit pro-inflammatory functions from innate cells, like NK cells and DCs. However, activated 
CD4 T cells can also respond to these stimuli. Large numbers of Th1 cells can produce IFN-γ in 
response to LPS during Salmonella infection. In this chapter we extend that observation to 
Chlamydia infection and other innate ligands, and examine the kinetics of the innate Th1 
response over time. 
 
 
Previous work from our laboratory examined the ability of LPS to stimulate Th1 cells to 
produce IFN-γ during Salmonella infection (Srinivasan et al., 2007). Further, as discussed 
above, a number of non-cognate interactions have been shown to amplify T cell 
responses, although these have typically looked at CD8 T cells (Freeman et al., 2012; 
Raué et al., 2004). In this chapter, we focus on Th1 cells to examine the kinetics of this 
response and determine under what circumstances Th1 cells can be innately stimulated. 
We show that while activation and differentiation of Th1 cells are not altered by 
administration of innate stimuli, various ligands of extracellular TLRs can elicit strong 
IFN-γ production from Th1 cells. Further, LPS stimulation is dose-dependent, occurs 
throughout Salmonella infection, and during Chlamydia infection as well. These findings 
illustrate the versatility of the Th1 response to innate stimuli and suggest a broad 
application for this response pathway. 
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Results 
Th1 cell activation and effector function after LPS stimulation 
Innate amplification of Th1 effector responses was primarily explored within our work in 
the context of a model of systemic salmonellosis, because of the strong CD4 T cell 
response that occurs during this infection. To establish systemic salmonellosis, an 
attenuated strain of Salmonella (BRD509) was administered i.v. to C57BL/6 mice. At 2 
weeks post-infection the CD4 T cell population has expanded and differentiated into a 
strong Th1 response, thus we administered LPS stimulation at this timepoint i.v. and 
waited 4 hours to examine the effect of this stimulation on Th1 cell IFN-γ production, as 
assessed by flow cytometry.  
In order to describe this response further, we first showed that during Salmonella 
infection the CD44hi population of both CD4 and CD8 T cells produce IFN-γ in response 
to 4 hour in vivo LPS stimulation, confirming our previous findings (Figs 1-2a and b, 
bottom row). In these experiments, it is important to note that LPS stimulation of 
uninfected mice in contrast did not elicit an IFN-γ response (Fig 1-2a and b, top row). 
Uninfected control mice did not exhibit IFN-γ production in response to any conditions 
tested in the context of our work, and as such, although they were included in most of the 
experiments, they are often not shown in the results. We then go on to demonstrate that 
the IFN-γ-producing CD4 T cells in these mice contained the transcription factor T-bet, 
thus confirming that these were Th1 cells (Fig 1-2c).  
Next, we characterized the kinetics of this response over time to show that administration 
of innate stimulation did not alter T cell activation or differentiation of Th1 cells. The 
first timepoint of these kinetics illustrates the response of naïve (uninfected) mice, and 
then samples were taken at day 6 (week 1), weeks 2, 3, 4, 6, 8, 12, and 24 post-infection. 
Salmonella infection is typically cleared by around week 8 post-infection, thus the last 2 
timepoints should technically represent the memory response post clearance. Throughout 
the course of infection, LPS stimulation did not impact activation, measured by the 
percent of CD44hi CD4 or CD8 T cells in the LPS stimulated (gray line) compared to the 
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unstimulated (black line) mice (Figs 1-3a and b, respectively). Further, this stimulation 
did not change the ability of CD4 T cells to develop into Th1 cells, since the kinetics of 
T-bet expression with or without stimuli was not changed (Fig 1-3c).  
In contrast, production of IFN-γ throughout the course of infection was remarkably 
altered by LPS stimulation. Throughout this work, we examine production of IFN-γ by 
Th1 cells as the relative proportion of T-bet+ CD4+ T cells producing IFN-γ out of the T-
bet+ CD4+ T cell total, all of which should be capable of IFN-γ production. In other 
words, (IFN-γ+ T-bet+ CD4+)/(T-bet+ CD4+ total). Thus, we are comparing the 
proportion of Th1 cells which become stimulated. A proportion of Th1 cells were 
producing IFN-γ at any given point throughout the infection in response to the cognate 
and non-cognate interactions provided by the infection itself, with a maximal response 
observed at 2 weeks post-infection (Fig 1-4a). However, providing LPS stimulation at 
any of the timepoints examined increased this Th1 response, demonstrating that innate 
stimulation of Th1 can occur throughout infection, and in fact continued to be observed at 
low levels even after infection (weeks 12 and 24 post-infection). A similar response was 
seen in CD44hi CD8+ T cells, at lower levels (Fig 1-4b). 
Innate Th1 stimulation occurs during both Salmonella and Chlamydia infections 
We next wanted to determine whether this innate response of Th1 cells occurs 
particularly during Salmonella infection, or whether this responsiveness could be 
observed during any infection that is able to induce a strong Th1 cell response. Th1-
dominant responses are generated during intracellular infections, so we chose to examine 
another intracellular pathogen for which a strong Th1 response has been observed. 
Chlamydia muridarum is an intracellular bacteria for which it has been shown that IFN-γ 
production is required to prevent bacterial dissemination. C57BL/6 mice infected 
systemically with Chlamydia showed differentiation of a Th1 cell population, and upon 
LPS stimulation these Th1 cells were also able to produce IFN-γ (Fig 1-5a and b). As 
with Salmonella infection, CD8 T cells were also innately stimulated during Chlamydia 
infection (Fig 1-5c), albeit to a lesser extent than was seen for CD4 T cells in either 
infection. Further, both CD4 and CD8 T cells in Chlamydia infected mice that had not 
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received additional innate stimulation (no stim) produced small amounts of IFN-γ, as 
seen in Salmonella infection. 
Extracellular TLR ligands elicit Th1 stimulation 
Thus far, we have examined the ability of LPS to stimulate IFN-γ production, however, 
we hypothesized that this was not an LPS-specific response, but rather a broader response 
to innate stimuli. To test this, we administered a broad range of TLR ligands during 
Salmonella infection and examined their ability to elicit IFN-γ production. Interestingly, 
while Th1 cells produced IFN-γ in response to LPS, flagellin, and Pam3CSK4, they did 
not exhibit significantly increased production of IFN-γ after stimulation with CpG DNA 
or Imiquimod (Fig 1-6a and b). A similar, but smaller, response pattern was observed in 
CD8 T cells (Fig 1-6c). Further, the response to LPS administration was dose-dependent 
in both Th1 and CD8 T cells (Fig 1-7a and b). 
Discussion 
Together, these data demonstrate that T cells can be stimulated to produce IFN-γ under a 
broad variety of conditions and throughout infection, suggesting that this pathway has 
broad implications to the function of T cells. Stimulation occurred during both 
Salmonella and Chlamydia infection, supporting the idea that this response pathway may 
be important in a range of intracellular infections. Future work exploring additional 
infectious contexts is required to determine whether innate CD4 T cell stimulation occurs 
as a general rule of T cell function. Further, innate T cell stimulation was not limited to 
LPS, occurring in response to LPS, flagellin, and Pam3CSK4, although not CpG DNA or 
Imiquimod. This may be due to the cellular location of the receptors that recognize these 
ligands. TLR4 (recognizes LPS), TLR5 (flagellin), and the heterodimeric complex of 
TLR1 and 2 (triacylated lipopeptides, such as Pam3CSK4) are all expressed on the cell 
surface and can therefore recognize extracellular innate ligands. In contrast, TLR7 
(single-stranded RNA, such as Imiquimod) and TLR9 (CpG DNA) are expressed within 
the cell, recognizing innate ligands in the endosome. This suggests that the reason for the 
response to some but not other TLR ligands may be explained by the direct 
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administration of ligands that cannot be internalized on their own to interact with their 
receptor. 
Further, the response to LPS was dose-dependent, with a small level of stimulation 
observed at doses as low as 0.1 µg per mouse. This supports the assertion that innate 
stimulation of T cells occurs in response to the lower levels of innate ligands produced 
during the course of a normal infection without the addition of exogenous TLR ligands. 
In our system, high doses of ligands were used to observe large and quantifiable effects 
upon T cell responses. However, in our system mice only have to survive this strong 
cytokine response for 4 hours, and in fact many did not survive that long with doses at 25 
µg per mouse or higher. Thus, to balance the toxicity of the inflammatory response 
against the anti-bacterial effects of these cytokines, a delicate balance is required. It is 
likely that a proportion of the small IFN-γ response observed in infected, unstimulated 
controls is due to the innate stimulation of ligands produced by the infection itself. In 
chapter 4 we will explore the effect that losing even this small proportion of the response 
has on the overall ability of T cells to fight Salmonella infection. 
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Figure 1-2: LPS stimulates activated T cells to produce IFN-γ during infection 
C57BL/6 mice were infected i.v. with 5x105 Salmonella (BRD509) and the proportion of CD4+ 
and CD8+ T cells in the spleen that express CD44 and IFN-γ (or T-bet on CD4+ T cells) was 
assessed by flow cytometry. Four hours prior to analysis, mice were injected i.v. with 10µg LPS 
or received no additional stimulus (no stim). Representative flow cytometry plots showing the 
production of IFN-γ at day 14 after infection by (A) CD44hi CD4+ and (B) CD44hi CD8+ T cells, 
or (C) T-bet+ CD4+ T cells. Numbers show the percentage of IFN-γ positive or negative T cells 
within the boxed gates. Experiments contained at least 3 mice/group at each time point and 
representative flow cytometry plots show data that are representative of at least three 
experiments. Error bars represent mean +/- SEM. 
A B 
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Figure 1-3: Kinetics of activation and Th1 differentiation are not altered by innate 
stimulation 
C57BL/6 mice were infected i.v. with 5x105 Salmonella (BRD509) and at various times later, the 
proportion of CD4+ and CD8+ T cells in the spleen that express CD44 and IFN-γ or T-bet on 
CD4+ T cells was assessed by flow cytometry. Four hours prior to analysis, mice were injected 
i.v. with 10µg LPS or received no additional stimulus (no stim). Graphs show change in the 
percentage of (A) CD44hi CD4+, (B) CD44hi CD8+, or (C) T-bet+ CD4+ over time in the spleen. 
Experiments contained at least 3 mice/group at each time point and show data that are 
representative of at least three experiments. Error bars represent mean +/- SEM. 
C 
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Figure 1-4: Kinetics of IFN-γ production in response to LPS 
C57BL/6 mice were infected i.v. with 5x105 Salmonella (BRD509) and at multiple times later 
splenocytes were assessed for IFN-γ production by flow cytometry. Four hours prior to analysis, 
mice were injected i.v. with 10µg LPS or received no additional stimulus (no stim). Graphs show 
change in the percentage of (A) IFN-γ+ T-bet+ CD4+ Tcells (percentage of Th1 cells producing 
IFN-γ) and (B) IFN-γ+ CD44hi (percentage of activated CD8+ T cells producing IFN-γ) in the 
spleen. Experiments contained at least 3 mice/group at each time point and data are representative 
of at least three experiments. Error bars represent mean +/- SEM. 
A B 
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Figure 1-5: T cells also produce IFN-γ after LPS stimulation during Chlamydia infection 
C57BL/6 mice were infected i.v. with 1x107 Chlamydia muridarum Ebs. One week later, infected 
or uninfected mice were injected i.v. with LPS and spleens harvested four hours later to 
determine IFN-γ production. Representative (A) flow cytometry plots and bar graphs of 
combined data showing (B) intracellular T-bet or (C) CD44 and IFN-γ staining in Chlamydia-
infected mice after gating on CD4+ or CD8+ as indicated. (B, C) Statistical significance was 
determined by two-way ANOVA with a bonferroni post-test. P< 0.005 (***), p<0.01 (**), or 
p>0.05 (ns). All experiments contain at least 3 mice/ group and were conducted at least twice. 
Error bars represent mean +/- SEM. 
A 
B C 
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Figure 1-6: Ligands of extracellular TLRs induce T cells to produce IFN-γ 
C57BL/6 mice were infected i.v. with 5x105 Salmonella. Two weeks later, infected or uninfected 
mice were injected i.v. with LPS, flagellin, CpG DNA, Imiquimod, or Pam3CSK4 and spleens 
harvested four hours later to determine IFN-γ production. Representative (A) flow cytometry 
plots and bar graphs of combined data showing (B) intracellular T-bet or (C) CD44 and IFN-γ 
staining in Salmonella-infected mice after gating on CD4+ or CD8+. (B, C) Statistical significance 
was determined by two-way ANOVA with a bonferroni post-test. P< 0.005 (***), p<0.01 (**), or 
p>0.05 (ns). All experiments contain at least 3 mice/ group and were conducted at least twice. 
Error bars represent mean +/- SEM. 
B C 
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Figure 1-7: T cell response to LPS is dose-dependent 
C57BL/6 mice were infected i.v. with 5x105 Salmonella. Two weeks later, infected or uninfected 
mice were injected i.v. with LPS and spleens harvested four hours later to determine IFN-γ 
production. Graphs show percentage of IFN-γ+ cells after i.v. LPS administration at various 
doses. CD4+ are shown as percentage of total T-bet+ cells producing IFN-γ and CD8+ as 
percentage IFN-γ+ of total CD44hi. All experiments contain at least 3 mice/ group and were 
conducted at least twice. Error bars represent mean +/- SEM. 
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Chapter 2:  
How do T cells recognize innate stimulation? 
 
Figure 2-1: Recognition of innate ligands could be directly or indirectly mediated 
Th1 cells recognize various innate ligands, resulting in production of IFN-γ as demonstrated in 
Chapter 1. However, this response could be due to direct PRR signaling or indirect stimulation by 
PRR expressing innate cells. In this chapter we focus on the T cell intrinsic signals required to 
mediate the innate Th1 response.  
 
 
In Chapter 1 we established that Th1 cells can respond to many different innate stimuli in 
the context of multiple intracellular infections throughout the course of infection. In this 
chapter we begin to examine the mechanisms for how this response occurs. Recognition 
of TLR ligands could occur directly by the expression of TLRs on the Th1 cells, or 
indirectly by TLR recognition on innate cells that produce secondary signals, which then 
trigger a Th1 response. This chapter focuses on the T cell intrinsic requirements of innate 
Th1 stimulation, showing that MyD88-dependent IL-18 and IL-33 receptor signaling are 
necessary for the maximal Th1 response, while TLR4, IL-1R and IFN-γR signaling are 
not necessary to elicit IFN-γ production after LPS stimulation. 
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Results 
Direct TLR4 recognition is not required for T cell response to LPS 
To distinguish between direct and indirect mechanisms of T cell stimulation we first 
needed a way to compare functional and deficient T cells within an otherwise similar 
environment. In the case of TLR4 recognition of LPS, for example, it has been proposed 
that direct TLR4 signaling on the T cell may mediate a variety of effects upon T cell 
function (Reynolds and Dong, 2013). However, using conventional TLR4-deficient mice 
it is impossible to separate the potential effects of direct TLR4 signaling on the T cell 
from the well-established effects of TLR4 signaling on other cell types that could 
indirectly influence T cell function. To resolve this uncertainty, we utilized a well-
established tool for generating mice that contain multiple distinct cell populations: mixed 
bone marrow chimeras. In a mixed bone marrow chimera (BMC), a host is irradiated and 
reconstituted with a mix of bone marrow, in our case from both a wild-type and a 
deficient mouse. Each of these mice generally presents different cell surface markers that 
allow them to be distinguished from one another by flow cytometry. When the bone 
marrow cells have expanded to replace the original host cells lost by irradiation, they can 
be looked at by flow cytometry as distinct populations, as illustrated in Fig 2-2. These 
plots show 3 separate populations representing the endogenous (host) cells, the 
transferred wild-type cells, and the transferred deficient cells, as labelled. This enables 
examination of the cell function based solely on the intrinsic deficiency. 
The important point to remember here is that while the T cells being compared are 
intrinsically different, their environment is not. Although other cell types will also be 
affected by the same deficiencies, since both the deficient and normal T cells exist within 
the same environment, these extrinsic deficiencies should impact each population 
similarly. While this may result in an overall impairment in all T cell responses, by 
comparing T cell functions within the same host these effects are taken into account. 
Thus, BMCs are a powerful tool to examine the effect of T-cell specific deficiencies. 
We first used this tool to address the question of direct or indirect LPS recognition by 
making TLR4-deficient BMCs. If direct TLR4 recognition on T cells were required for 
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LPS to cause innate stimulation, these mice would display defective IFN-γ production in 
the TLR4-deficient T cells, but not in the wild-type T cells. However, if the effect of LPS 
on T cells occurs indirectly, with recognition occuring on other cell types that can then 
influence the T cell response, both deficient and wild-type T cells should be similarly 
affected by the loss of TLR4 on a portion of the other cells. These mice conclusively 
demonstrated that direct TLR4 signaling on T cells is not required for LPS stimulation of 
IFN-γ production, since TLR4-deficient T cells produced IFN-γ at the same rate as wild-
type T cells (Fig 2-3). Further, both T cell populations maintained strong IFN-γ 
production, suggesting that the loss of TLR4 in some of the other cells did not 
sufficiently lower the overall reponse to LPS. Given that direct LPS recognition by T 
cells is not required, we next examined what pathways might mediate an indirect 
response by T cells. 
Innate stimulation of T cells requires intrinsic MyD88 signaling 
All TLRs contain an intracellular signalling domain known as a TIR (toll/IL-1R) domain 
that allows them to interact with TIR domain-containing signaling molecules, such as 
MyD88. However, as the name TIR implies, TLRs are not the only receptors that contain 
TIR domains. The IL-1R family includes IL-1R, IL-18R, IL-33R, and the recently 
identified and poorly described IL-36R (Garlanda et al., 2013). To narrow down the 
possible interactions required by T cells, we decided to begin broadly by looking at the 
requirement for T cell-intrinsic MyD88. Again using BMCs, wild-type and MyD88-
deficient T cells were compared. Th1 cells lacking MyD88 signaling were severely 
deficient in IFN-γ production compared to wild-type Th1 cells in the same host after LPS 
stimulation (Fig 2-4a and b). While a small impairment in Th1 differentiation was also 
observed in MyD88-deficient CD4 T cells, these differences are factored in by displaying 
the results as IFN-γ production by T-bet+ CD4 T cells, since this calculation excludes 
cells that have not developed the capacity to produce IFN-γ. Similar results were seen in 
CD8 T cells from MyD88-deficient hosts (Fig 2-4c).  
IL-18R and IL-33R are necessary for maximal Th1 cell response 
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While the T cell response to innate stimuli requires MyD88 signaling, the role of MyD88 
is independent of TLR recognition, as seen earlier in Fig 2-3. As mentioned above, 
MyD88 mediates intracellular signaling for both the TLR and IL-1R families. In addition, 
IFN-γR has been shown to be able to use MyD88, although this receptor is usually 
thought to utilize Jak/STAT signaling. Thus, the requirement for MyD88 must be due to a 
role for one or more of the following receptors: IL-1R, IL-18R, IL-33R, IL-36R, and 
IFN-γR. Each of the IL-1 receptors is a heterodimeric complex consisting of a unique 
recognition chain and a signaling chain, which in the case of IL-1R, IL-33R, and IL-36R 
are the same chain, IL-1Rap. We tested each of these receptors individually by generating 
BMCs with mice deficient in the unique recognition chains, with the exception of IL-
36R, which is not yet commercially available. Both IL-1R1-deficient and IFN-γR1-
deficient T cells showed no impairment as compared to the wild-type T cells in the same 
mice, for either Th1 cells (Fig 2-5a and b) or CD8 T cells (Fig 2-5c and d).   
Additionally, we examined IL-18R1- and IL-1Rl1 (IL-33R)-deficient BMCs. Loss of 
IL18 signaling in Th1 cells closely mirrored the effects of MyD88 loss, with a small 
decrease in Th1 cell frequency and a severe defecit in IFN-γ production in response to 
innate stimulation (Fig 2-6a). CD8 T cells also required IL-18R for stimulation (Fig 2-
6c). Perhaps surprisingly, loss of IL-33 signaling also impaired Th1 production of IFN-γ 
by a smaller, but still highly significant amount (Fig 2-6b). While these results were not 
reflected in the CD8 T cells (Fig 2-6d), this may simply be due to the smaller percentage 
of activated CD8 T cells, from which a small change would be difficult to observe. 
Discussion 
The data in this chapter demonstrate that while the ability of Th1 cells to respond to 
innate stimuli requires MyD88 signaling, it is not mediated by direct TLR signaling. 
Innate stimuli interact directly with other cell types, and these cells produce cytokines 
that allow an indirect stimulation of T cells. Given the requirement for MyD88, a series 
of BMCs were generated to test receptors known to utilize MyD88 signaling. T cell 
intrinsic IL-18R signaling was shown to be required for innate Th1 stimulation, which on 
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its own sufficiently explains the deficiency resulting from loss of MyD88. However, 
surprisingly an effect was also seen in Th1 cells deficient for IL33R. 
IL-33 has primarily been described, within the context of T cell stimulation, as a Th2 
associated cytokine. However, some reports describe it as a generally pro-inflammatory 
cytokine. Prior to being secreted, IL-33 has the unique capacity to act as a transcription 
factor, with a possible role in NF-κb regulation recently described. Thus, it has been 
proposed that the release of IL-33 from the cell may serve as a signal of cell damage. 
Although the impact of IL-18R-deficiency on Th1 cells was certainly more severe than 
that seen for IL-33R-deficiency, these results suggest that IL-33 may further amplify the 
Th1 response during infection.  
While these results indicate that IL-18 is required for innate stimulation, and that IL-33 
may further stimulate this response, they do not establish whether these cytokine signals 
are sufficient to cause innate stimulation on their own. It is likely that additional 
inflammatory signals exist that can amplify this innate response. In fact, recently in vitro 
cytokine stimulation of effector or memory CD8 T cells was examined for 43 different 
cytokines, either alone or in pairs (Freeman et al., 2012). The results demonstrated a 
surprising promiscuity, with many cytokine pairs resulting in IFN-γ production. This 
suggests that innate stimulation of both CD4 and CD8 T cells still requires further 
exploration in vivo to fully understand how these responses can be induced naturally 
during infection. Further, while our work has focused on elicitation of IFN-γ from Th1 
cells, to fully appreciate the role of innate CD4 T cell stimulation future work will need 
to examine whether similar stimulation can elicit effector responses from other CD4 T 
cell subsets.  
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Figure 2-2: Flow cytometry gating strategy used for mixed bone marrow chimeras  
CD45.1+ C57BL/6 mice were irradiated and reconstituted with a mixture of bone marrow from 
wild-type (CD90.1+ CD45.2+) and various gene-deficient (CD90.2+ CD45.2+) mice. After 
immune reconstitution BM chimeras were infected i.v. with 5x105 Salmonella and response to 
LPS determined in the spleen. Gating strategy used to examine donor wild-type and gene-
deficient CD4+ T cells in mixed bone marrow chimeras (MBCs). Splenocytes were gated as live, 
singlets, and CD4+ CD8-, then gated as shown in the left panel for congenic markers. Each gated 
cell population was assessed for IFN-γ production and either CD11a (TLR4) or T-bet.  
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Figure 2-3: TLR4 is not intrinsically required for innate T cell stimulation by LPS 
CD45.1+ C57BL/6 mice were irradiated and reconstituted with a mixture of bone marrow from 
wild-type (CD90.1+ CD45.2+) and TLR4-deficient (CD90.2+ CD45.2+) mice. After immune 
reconstitution BM chimeras were infected i.v. with 5x105 Salmonella and response to LPS 
determined in the spleen. Representative (A) flow cytometry plots and a graph of combined data 
for (B) CD4+ CD11ahi and (C) CD8+ CD11ahi are shown for TLR4 deficient MBCs. All 
experiments include at least 3 mice per group and were performed at least twice with similar 
results. Statistical analyses were performed by two-way repeated measures ANOVA with 
bonferroni post-test. Error bars represent mean +/- SEM. 
A 
B C 
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Figure 2-4: T cell response to LPS requires intrinsic MyD88 signaling 
CD45.1+ C57BL/6 mice were irradiated and reconstituted with a mixture of bone marrow from 
wild-type (CD90.1+ CD45.2+) and MyD88-deficient (CD90.2+ CD45.2+) mice. After immune 
reconstitution BM chimeras were infected i.v. with 5x105 Salmonella and response to LPS 
determined in the spleen. Representative (A) flow cytometry plots and a graph of combined data 
for (B) CD4+ T-bet+ and (C) CD8+ are shown for MyD88-deficient MBCs. All experiments 
include at least 3 mice per group and were performed at least twice with similar results. Statistical 
analyses were performed by two-way repeated measures ANOVA with bonferroni post-test. Error 
bars represent mean +/- SEM. 
A 
B C 
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Figure 2-5: T cell response to LPS does not require intrinsic IL1R or IFN-γR signaling 
MBCs were generated, infected, and stimulated, as described in Figure 2-2. A graph showing the 
percentage of IFN-γ+ (A, B) Th1 cells and (C, D) total CD8+ cells in wild-type versus gene-
deficient CD4+ and CD8+ T cells is shown for (A, C) IL-1r1 and (B, D) IFN-γr1 MBCs. All 
experiments include at least 3 mice per group and were performed at least twice with similar 
results. Statistical analyses were performed by two-way repeated measures ANOVA with 
bonferroni post-test. Error bars represent mean +/- SEM. 
C 
A B 
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Figure 2-6: Loss of intrinsic IL18R or IL33R signaling impairs innate T cell response 
MBCs were generated, infected, and stimulated, as described in Figure 2-2. A graph showing the 
percentage of IFN-γ+ (A, B) Th1 cells and (C, D) total CD8+ cells in wild-type versus gene-
deficient CD4+ and CD8+ T cells is shown for (A, C) IL-18r1 and (B, D) IL-1rl1 (IL-33R) MBCs. 
All experiments include at least 3 mice per group and were performed at least twice with similar 
results. Statistical analyses were performed by two-way repeated measures ANOVA with 
bonferroni post-test. Error bars represent mean +/- SEM. 
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Chapter 3:  
How do PRRs elicit T cell effector functions? 
 
Figure 3-1: Innate T cell 
stimulation requires 
multiple PRR pathways 
Administration of innate 
stimuli during infection 
amplifies the innate 
response to the infecting 
pathogen. In the last 
chapter we showed that 
innate stimulation of Th1 
cells requires IL-18. In 
this chapter we focus on 
how innate stimuli lead to 
IL-18 production. 
 
 
 
 
 
 
 
 
 
 
 
In Chapter 2 we demonstrate that the recognition of TLR ligands by T cells is indirectly 
mediated, in part, by IL-18. In this chapter, we next address the question of how IL-18 is 
induced by innate stimuli. We show that both TLR4 and the inflammasome components 
NLRP3 and NLRC4 are required for T cells to produce IFN-γ in response to LPS 
stimulation. However, aflagellate Salmonella induced the same response as flagellated 
Salmonella, implying redundant inflammasome recognition of stimuli other than 
flagellin. Further, the loss of inflammasomes resulted in lower circulating levels of IL-18, 
most likely due to impaired secretion. These results suggest that both TLR and NLR 
signals are required to innately stimulate T cells, and offer one possible explanation for 
the requirement of a concurrent infection for optimal T cell response to innate stimuli. 
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Results 
LPS stimulation increases mRNA and circulating levels of IFN-γ and IL-18 
Although our T cell-intrinsic studies in chapter 2 show that IL-18 and IL-33 receptors are 
required for maximal T cell stimulation by LPS, in order for these cytokines to mediate 
the indirect effects of LPS administration they would need to increase in response to LPS. 
RT-QPCR of mRNA extracted from total splenocytes or total hepatocytes showed an 
increase after LPS stimulation of the transcripts for IFN-γ, IL-18, and IL-33, as well as 
IL-12, which has been shown to act synergistically with IL-18 (Table 3-1). Further, 
cytokine ELISAs (performed by Oanh Pham) on sera collected from mice 4 hours after 
LPS stimulation displayed a dramatic increase in circulating levels of IFN-γ, from around 
3000 pg/ml in an infected mouse to nearly 106 pg/ml in infected mice after LPS 
stimulation (Fig 3-2a). This demonstrates that not only are more T cells producing IFN-γ, 
but that the impact of innate stimulation on overall IFN-γ levels is severe. In support of 
our earlier data, a greater than 30-fold increase in circulating IL-18 was also observed 
after LPS stimulation, confirming its availability as a mediator of the T cell response to 
LPS (Fig 3-2b). Cytokine ELISAs for both IL-12 and IL-33 were attempted on the same 
sera samples, but all samples were below the limit of detection. For this reason, 
circulating cytokine levels in the remaining figures focus on IL-18 production. 
Ability of TLR ligands to increase circulating IL-18 reflects their T cell stimulating 
capacity 
Given the evidence above that IL-18 production after innate stimulation correlated with 
both circulating IFN-γ levels and T cell production of IFN-γ observed by FACS, we next 
asked whether IL-18 is produced after stimulation with innate ligands that do not result in 
IFN-γ production. In chapter 1 we demonstrate that T cells respond to ligands for 
extracellular, but not endosomal, TLRs. We hypothesize that this is due to their location, 
and that this prevents recognition of exogenous ligands by phagosomal receptors. If this 
is true, than these ligands should also not be able to stimulate IL-18 production. Serum 
cytokine ELISAs confirmed that while LPS, flagellin, and Pam3CSK4 were able to 
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stimulate increased circulating IFN-γ levels, Imiquimod was not (Fig 3-3a). Further, as 
predicted, Imiquimod did not result in IL-18 production, while LPS, flagellin, and 
Pam3CSK4 all increased IL-18 (Fig 3-3b). 
Inflammasome processing of IL-18 is required for innate T cell stimulation   
Since IL-18 appears to play a pivotal role in this response pathway, we next wanted to 
explore the requirements for IL-18 production. IL-18, like IL-1, is first expressed as a 
pro-peptide requiring caspase-cleavage for maturation and secretion. Caspase maturation 
is one of the hallmark functions of the NLRC4 inflammasome, which recognizes 
flagellin. Previous work has shown that during Salmonella infection both NLRC4 and 
NLRP3 are required, but the ligand for NLRP3 during Salmonella is unclear (Broz et al., 
2010). Therefore, we asked whether recognition of innate stimuli by these 
inflammasomes could be indirectly involved in the T cell response pathway. Mice 
deficient for both NLRC4 and NLRP3 produced markedly less IL-18 after stimulation 
with either LPS or flagellin (Fig 3-4). Interestingly, a small amount of IL-18 was still 
produced in response to stimulation, despite the loss of both inflammasome pathways. 
Further, stimulation of either Th1 or CD8 T cells was severely hampered by the loss of 
these inflammasome molecules, presumably due to the loss of IL-18 production (Fig 3-5a 
and b).  
Recognition of flagellin by the inflammasome is not required for innate T cell 
stimulation 
Recently, it was reported that NLRC4 recognition of flagellin is required for bystander 
stimulation of CD8 T cells during Salmonella infection (Kupz et al., 2012). This data is in 
agreement with our findings, particularly because they show a similar requirement for IL-
18. However, in their model this response occurs only in response to flagellin- no 
stimulation was observed after administration of LPS. We wanted to determine whether 
our response pathway is similarly dependent upon flagellin, or whether these are in fact 
different mechanisms. Although we typically administer LPS, the Salmonella itself may 
provide the necessary flagellin. Thus, to examine the role of NLRC4, we needed to 
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remove all flagellin from our system. To do this, an aflagellate BRD509 strain was 
generated in the Baumler lab. Infection with this strain followed by LPS stimulation 
elicited a similar IFN-γ response from both Th1 and CD8 T cells as in wild-type 
BRD509, despite the absence of flagellin stimulation, suggesting that the requirement for 
inflammasome signaling in our model relies on redundant NLR ligands (Fig 3-6a and b).  
TLR4 is required for innate stimulation of T cells by LPS  
Finally, there is some evidence that LPS can be recognized by NLRP3. We show in 
chapter 2 that T cell intrinsic TLR4 recognition of LPS is not required to mediate T cell 
stimulation. However, in light of the requirement for inflammsome signaling, we wanted 
to confirm that T cell extrinsic TLR4 recognition of LPS does in fact mediate innate 
stimulation. TLR4-deficient mice were infected with BRD509 and stimulated with LPS 
as usual, and IFN-γ production by both Th1 and CD8 T cells was examined (Fig 3-7a and 
b). In the absence of TLR4, no response to LPS was able to occur. Combined with the 
MBC data from Figure 2-3, these data demonstrate that the T cell response to LPS is 
mediated indirectly by TLR4.  
Discussion 
In this chapter, we characterize some of the T cell extrinsic mechanisms that result from 
innate stimulation and can mediate stimulation of T cells. Upregulation of mRNA 
transcripts for IFN-γ, IL-18, IL-33 and IL-12 were all observed in splenocytes and 
hepatocytes after LPS stimulation, although only IFN-γ and IL-18 were found in 
circulation. It is possible that these cytokines are upregulated after stimulation, but are 
not able to be secreted within the 4 hour window used in this assay, or that additional 
post-transcriptional regulation prevents expression or secretion. Further, because IL-33 
can also act as a transcription factor, it is possible that IL-33 mRNA is upregulated for 
this purpose rather than for secretion as a cytokine. All of these explanations would 
suggest that neither cytokine mediates the effect of LPS upon T cells, although it does not 
rule out the possibility that the levels induced by the infection itself are sufficient to 
provide T cell stimulatory effects without requiring LPS mediated amplification. It is also 
possible that these cytokines are secreted at higher levels after LPS stimulation and do 
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increase T cell responses, but that they are primarily retained in the tissue rather than 
circulating in the sera. 
Both the production of and the requirement for IL-18 are clear in this pathway, therefore 
we examined the mechanism leading to IL-18 production after innate stimulation. Not 
only were all of the ligands of the extracellular TLRs tested able to induce IL-18 
production, but the inflammasome components NLRP3 and NLRC4 were also required. 
Interestingly, a small amount of IL-18 was still seen after stimulation in the absence of 
either inflammasome, suggesting that either an additional caspase-1 activating 
inflammasome is stimulated during Salmonella infection, or that caspase-1-independent 
maturation of IL-18 occurred. In fact, there is evidence for caspase-8 mediated 
maturation of both IL-18 and IL-1β (Bossaller et al., 2012). The signals that allow for 
caspase 8 activation are still unclear, but may involve an NLRP3/NLRC4 inflammasome-
independent pathway (Broz and Monack, 2013). Together, these findings may explain the 
low level of seemingly inflammasome-independent IL-18 and IFN-γ production.  
The requirement for both TLR and NLR signaling for a strong T cell response to innate 
stimuli demonstrates a mechanism in which during infection simultaneous stimulation of 
both the TLR and NLR pathways results in cytokines that are able to amplify the T cell 
response. While it is remotely possible that the TLR ligands administered were also able 
to provide NLR stimulation, it is unlikely given the timing and intracytoplasmic location 
of the NLRs. More likely, the NLR stimulation was provided by the infection itself, 
either by production of PAMPs or by damage resulting in DAMPs. This theory would 
also explain why administration of innate ligands alone is not sufficient to result in 
production of large amounts of IL-18 or IFN-γ in uninfected mice. Further, this dual 
requirement suggests that a pathway has evolved to allow the innate recognition of 
pathogens and damage to be communicated to the adaptive T cell response. Clarification 
of the mechanisms of this response in different models is needed to demonstrate whether 
this communication is a function inherent in all T cell responses. 
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   effect	  of	  LPS 	  (relative	  to	  unstimulated	  controls)	  
Spleen	   	  gene:	   IFN-­‐γ	   IL12 IL18 IL33 
	   naïve 1 1 1 1 
	   naïve	  +	  LPS 8.67	   0.99	   1.30	   1.60	  
	   d14 1 1 1 1 
	   d14	  +	  LPS 22.02	   4.52	   2.26	   5.35	  
	   	   	   	   	   	  
Liver	   	   	   	   	   	  
	   naïve 1 1 1 1 
	   naïve	  +	  LPS 11.07	   1.47	   1.96 6.16 
	   d14 1 1 1 1 
	   d14	  +	  LPS 27.9 5.36	   2.6 16.2 
 
Table 3-1: LPS stimulation leads to increased mRNA expression of IFN-γ, IL-12, IL-18, and 
IL-33 
C57BL/6 mice were infected i.v. with 5x105 Salmonella and two weeks later, infected or 
uninfected mice were injected i.v. with LPS. Spleens and livers were harvested four hours later 
and RT-QPCR performed on extracted mRNA. Numbers shown are normalized to gapdh 
expression and indicate the fold-change increase over unstimulated mice. 
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Figure 3-2: LPS stimulation elicits systemic IFN-γ and IL-18 production 
C57BL/6 mice were infected i.v. with 5x105 Salmonella BRD509 and the splenic response to LPS 
injection determined 2 weeks later, and four hours after stimulation. Plots show serum cytokine 
concentrations as determined by ELISA, for (A) IFN-γ and (B) IL-18. Data shown are pooled 
from 2 experiments. Statistical significance was determined by two-way ANOVA with a 
bonferroni post-test. Error bars represent mean +/- SEM. 
B 
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Figure 3-3: Extracellular TLR ligands elicit increased systemic IFN-γ and IL-18 
C57BL/6 mice were infected i.v. with 5x105 BRD509 and the splenic response to LPS, flagellin, 
Pam3CSK4, and Imiquimod injection determined 2 weeks later, and four hours after stimulation. 
Plots show serum cytokine concentrations as determined by ELISA, for (A) IFN-γ and (B) IL-18. 
Data shown are pooled from 2 experiments. Statistical significance was determined by two-way 
ANOVA with a bonferroni post-test. Error bars represent mean +/- SEM. 
B 
A 
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Figure 3-4: Impaired inflammasome signaling results in decreased systemic IL-18 after 
innate stimulation 
Wild-type or mice deficient in NLRP3 and NLRC4 were infected i.v. with 5x105 BRD509 and 
the splenic response to LPS or flagellin injection was determined 2 weeks later, and four hours 
after stimulation. Plots show serum cytokine concentrations as determined by ELISA for IL-18. 
Data shown are pooled from 2 experiments. Statistical significance was determined by two-way 
ANOVA with a bonferroni post-test. Error bars represent mean +/- SEM. 
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Figure 3-5: Innate stimulation of T cells requires inflammasome signaling 
Wild-type or mice deficient in NLRP3 and NLRC4 were infected i.v. with 5x105 BRD509 and 
the response to stimulation determined 2 weeks later, and four hours after stimulation. Plots show 
IFN-γ production by (A) Th1 cells or (B) CD8+ CD44hi T cells in Salmonella-infected wild-type, 
or mice lacking NLRP3 and NLRC4, after administration of LPS or flagellin. Data is pooled from 
2 experiments with more than 3 mice per group. Statistical significance was determined by two-
way ANOVA with a bonferroni post-test. Error bars represent mean +/- SEM. 
B 
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Figure 3-6: Innate T cell stimulation occurs independent of flagella 
C57BL/6 were infected i.v. with 5x105 Salmonella (BRD509 or flagellin-deficient BRD509) and 
the splenic response to LPS was determined 2 weeks later, and four hours after stimulation. IFN-γ 
production by (A) Th1 cells or (B) CD8+ CD44hi T cells after LPS stimulation of mice infected 
with BRD509 (flagellin-expressing) or a flagellin deficient mutant of BRD509 (ΔfliC ΔfljB). 
Data is representative of at least 2 experiments with at least 3 mice per group. Statistical 
significance was determined by two-way ANOVA with a bonferroni post-test. Error bars 
represent mean +/- SEM. 
B 
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Figure 3-7: TLR4 is extrinsically required for innate T cell stimulation by LPS 
TLR4 is required for response to LPS. Wild-type (C57BL/6) or TLR4-deficient mice were 
infected with BRD509 iv 14 days prior to stimulation with 10µg LPS i.v. 4 hours after stimulation 
mice were euthanized and spleens were removed and prepared for flow cytometry. Graphs 
indicate (A) the % of total T-bet+ CD4 T cells that produced IFN-γ or (B) the % of total CD44hi 
CD8 T cells that produced IFN-γ. Statistical significance was determined by two-way ANOVA 
with a bonferroni post-test. P< 0.005 (***) or p>0.05 (ns). 
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Chapter 4: 
Does innate stimulation of Th1 cells impact bacterial clearance? 
 
 
 
 
 
 
 
Figure 4-1: IFN-γ elicited by innate stimulation of 
T cells is a critical component of the Th1 response 
In the previous chapters we show a mechanism for 
innate stimulation of Th1 cells, as seen to the left. 
However, the significance of this response pathway is 
an equally critical question. In this chapter, the impact 
of innate T cell stimulation is examined to demonstrate 
that this response pathway not only can occur, but 
must occur for a normal Th1 response. 
 
 
 
The previous chapters have demonstrated that during infection various innate stimuli are 
able to trigger both TLR and NLR signaling pathways that result in pro-inflammatory 
cytokine secretion. This includes IL-18, which is required by Th1 cells to produce IFN-γ 
in response to innate stimuli. However, the fact that T cells can respond to high dose TLR 
ligand administration does not necessarily mean that this response is a major component 
of the response to infection. In this chapter, we use the information that IL-18 signaling is 
required for innate T cell response to explore the impact of the loss of this response on 
infection outcome. We show that T cell-intrinsic MyD88 deficiency impairs bacterial 
clearance, suggesting that this response is a critical component of an efficient Th1 
response. 
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Results 
CD4 T cells are required for Salmonella clearance and are a major source of IFN-γ 
after innate stimulation 
Before examining the effect of innate T cell responses, we first wanted to demonstrate the 
requirement of total CD4 T cell responses within our system. Previous work has shown 
that both CD4 T cells and IFN-γ are required during Salmonella infections. However, 
these studies were done with other strains of mice or bacteria than those used for our 
experiments. Thus, the extent of the deficiency that could be expected in our mice was 
unclear. Here, we show that loss of CD4 T cells from day 7 to day 30 of infection 
resulted in a greater than 50-fold increase in the splenic bacterial loads (Fig 4-2a). 
Depletion of CD8 T cells also led to increased bacterial burden, although to a lesser 
extent than loss of CD4. Bacterial loads in the liver were similarly increased in both 
groups (Fig 4-2b). Although loss of CD8 T cells impaired clearance, they did not appear 
to significantly compensate during CD4 depletion, since depletion of both CD4 and CD8 
did not result in significantly higher bacterial loads than those seen in the CD4 depletions 
alone. These results confirm in our model that CD4 T cells play a major role in bacterial 
clearance. Further, they set an upper threshold for our later experiments, since the role of 
innate stimulation in CD4 T cells would not be expected to exceed the requirement for 
CD4 T cells.  
While CD4 T cells are required, they have many functions. It is possible that their 
contribution to clearance is not through production of IFN-γ. Many cells are known to 
produce IFN-γ during Salmonella infection, and any of these has the potential to be 
influenced by innate stimulation, directly or indirectly. It is plausible that while CD4 T 
cells can produce IFN-γ, other cells contribute equally or more to IFN-γ levels, and 
therefore the production of IFN-γ by CD4 is not the function for which they are required. 
Thus, we next wanted to examine the sources of IFN-γ production after innate 
stimulation, to determine if CD4 T cells were a major contributor to IFN-γ levels. Flow 
cytometry gated on CD4+ or CD8+ splenocytes showed the high frequency of CD4+ T 
cells within the total live cell population, and the high frequency of those total CD4 T 
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cells that were producing IFN-γ at 3 different timepoints throughout infection (Fig 4-3a). 
The bar graph shows the relative frequency of each cell subset that produced IFN-γ after 
innate stimulation (Fig 4-3b), as gated in a.  
Mice with MyD88-deficient T cells show defects in survival, clearance, and 
resolution of Salmonella infection  
Given that CD4 T cells are required during Salmonella infection and are a major source 
of IFN-γ production after innate stimulation, we next wanted to find a way to ask what 
impact the innate production of IFN-γ by CD4 T cells has on the course of infection. To 
do this, we used the information gained in chapter 2 to design mice whose T cells lack an 
innate response, but are still capable of cognate activation and stimulation. Since we 
showed that MyD88 signaling was critical to innate stimulation of IFN-γ production, but 
did not prevent Th1 differentiation or IFN-γ production by other means, we generated 
mice with a T cell-specific deficiency in MyD88 using the cre-lox mouse system. Lck is a 
kinase involved in TCR signaling, thus by crossing Lck promoter driven cre-recombinase 
expressing mice to mice whose MyD88 gene is flanked by loxP sites, we were able to 
selectively knock-out MyD88 from T cells (called Lck-MyD88f/f for short). Thus, T cells 
are present, but unable to respond to innate cytokine stimulation. This provides a model 
for exploring the effect of innate T cell stimulation. 
During early Salmonella infection, the innate immune response plays a critical role in 
bacterial control. The requirement for CD4 T cells has typically begun to be observed 
around week 3, when the innate immune response fades and the T cell response must take 
over (Ravindran et al., 2005). Thus, we examined the role of innate T cell stimulation at 
later timepoints during infection, when T cell production of IFN-γ is most critical. At 5 
weeks post-infection, bacterial loads in wild-type mice should be declining. However, in 
the Lck-MyD88f/f mice we saw deaths beginning at 3 weeks, with 1 in 6 mice dying by 
the 5 week timepoint (Fig 4-4). Among the survivors, bacterial loads in the spleen were 
significantly higher in Lck-MyD88f/f mice than in either wild-type or the littermate (Lck-
MyD88f/w) controls (Fig 4-5a). Higher bacterial loads were also seen in the livers of these 
mice (Fig 4-5b).  
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Further, by 8 weeks post-infection mice in our model should be resolving Salmonella 
infection, showing low or no detectable bacterial loads. While we show 1 wild-type 
mouse with no detectable bacteria and most with bacteria no longer detectable in the 
draining lymph nodes, only 1 Lck-MyD88f/f mouse had no detectable bacteria in the 
draining lymph nodes and none had resolved infection (Fig 4-6a and b). Overall, bacterial 
loads in both spleen and mesenteric lymph nodes were significantly higher in the Lck-
MyD88f/f mice than in wild-type control mice. Together, these data demonstrate that 
innate stimulation of T cells can improve survival, bacterial clearance, and resolution of 
infection.   
Discussion 
In this chapter, we begin to explore the function of innate T cell stimulation. First, we 
showed that CD4 T cells are required for Salmonella clearance and that they composed a 
substantial proportion of the IFN-γ producing cells after innate stimulation. Then, we 
used the data from chapter 2 to design a system in which the T cell-specific response to 
innate stimuli is absent. In this model, we demonstrated that the innate T cell response 
improved survival, bacterial clearance and ultimately resolution of Salmonella infection. 
While we focused on the role of T cell stimulation during Salmonella infection here, we 
have established a model in which innate T cell responses can be explored further in a 
variety of contexts.  
Work in other labs has examined the role of MyD88 in T cells using other model 
systems. For example, it was recently shown that MyD88 is required in CD4 T cells for 
the resolution of Chlamydia infection (Frazer et al., 2013). This was done in a mixed 
BMC model, wherein mice were reconstituted with a mixture of CD4-deficient and 
MyD88-deficient bone marrow. However, studying infection outcomes in these mice 
presents problems, both as a result of the partial deficiencies in other cell types, and the 
effects of radiation on the non-hematopoietic compartment.  
Ultimately, the selective deficiency generated in cre-lox mice provides the best model 
currently available for interrogating innate T cell responses, with limited manipulation of 
the host or cells in question. Future work in these mice can further explore the 
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significance of innate T cell stimulation under various contexts, including additional 
infections. Although not currently available, this system could also be further refined in 
the future to allow for selective loss of innate T cell signaling using an inducible cre 
system. Tools such as these may be necessary to answer critical questions such as how 
innate T cell stimulation impacts fate decisions in order to separate the effects of innate 
stimulation in priming, stimulation, and re-activation. 
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Figure 4-2: Depletion of CD4 T cells severely impairs bacterial clearance during Salmonella 
infection 
T cell-depleted mice were infected i.v. with 5x105 Salmonella BRD509. Mice given PBS, anti-
CD4, anti-CD8, both, or an isotype control antibody were sacrificed at day 30 post-infection and 
bacterial loads in the (A) spleen and (B) liver were determined. Statistical significance was 
determined on log transformed data by one-way ANOVA. Error bars represent mean +/- SEM. 
B A 
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Figure 4-3: CD4+ T cells are the primary IFN-γ+ population after LPS stimulation 
CD4 T cells are the major producers of IFN-γ in the spleen throughout systemic Salmonella 
infection. C57BL/6 mice were infected with 5x105 BRD509 i.v. then stimulated with 10µg LPS at 
various timepoints post-infection, as indicated. After 4 hours, mice were euthanized and 
splenocytes prepared for flow cytometry. IFN-γ-producing populations were examined after a 
broad live gate and singlet gating here at days 6, 21, and 41 post-infection, representing the 
various stages of the T cell response. (A) Samples were gated on CD4+/ CD8-, CD8+/ CD4-, or 
CD4-/ CD8- populations as shown on the left, then for IFN-γ-production as shown in the 
histogram on the right. The CD4 are shown in red, the CD8 in blue, and the CD4-/CD8- are filled 
in gray. The red gate and %IFN-γ+ displayed on the histogram is %IFN-γ+ of CD4+, but the same 
gate was used for each population. (B) %IFN-γ+ CD4, CD8, or CD4-/ CD8- cells as gated in (A) 
were compiled for infected, LPS-stimulated mice at indicated timepoints. 
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Figure 4-4: Lck-cre x Myd88flox/flox mice display impaired survival during Salmonella 
infection 
Wild-type, Lck-cre x Myd88flox/flox homozygote and Lck-cre x Myd88flox/WT heterozygote mice 
were infected i.v. with 5x105 Salmonella BRD509 and monitored for 5 weeks post-infection. 
Survival curve shows combined data from at least 3 experiments and contains at least 10 mice per 
group. Wild-type and littermate control Lck-cre x Myd88flox/WT mice are grouped together as 
‘MyD88 sufficient T cells’. Lck-cre x Myd88flox/flox mice are shown as ‘MyD88 deficient T cells’. 
Statistical significance was observed by the Log-rank (Mantel-Cox) test.  
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Figure 4-5: Mice lacking MyD88 signalling in T cells show impaired Salmonella clearance 
Wild-type, Lck-cre x Myd88flox/flox homozygote, and Lck-cre x Myd88flox/WT heterozygote mice 
were infected i.v. with 5x105 Salmonella BRD509. Bacterial burdens in the (A) spleen and (B) 
liver were determined five weeks after infection. Gray (+) symbols show the number of mice that 
became moribund prior to assessment of bacterial burdens at the 5 week time point, also shown in 
the survival curve in Figure 4-3. Graphs represent pooled data from multiple experiments. 
Statistical significance was determined on log transformed data by one-way ANOVA. Error bars 
represent mean +/- SEM. 
B A 
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Figure 4-6: Resolution of Salmonella infection is impaired in mice with MyD88-deficient T 
cells 
Wild-type and Lck-cre x Myd88flox/flox homozygous mice were infected i.v. with 5x105 Salmonella 
BRD509. Bacterial burdens in the (A) spleen and (B) mesenteric lymph nodes (MLN) were 
determined eight weeks after infection. Dotted lines represent the limit of detection, and samples 
with no detected bacteria fall just below the line. Data is representative of one experiment. 
Statistical significance was determined on log transformed data by an unpaired, two-tailed T test. 
P< 0.05 (*). Error bars represent mean +/- SEM. 
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Conclusion 
Overview 
During an infection, T cells are activated by an interaction of TCRs and MHCs that allow 
a very powerful response to be limited to a pre-determined set of non-self antigens. This 
is an important control mechanism that limits severe immunopathology. However, once 
this checkpoint is passed in the secondary lymphoid tissues during initial T cell priming, 
the requirement of TCR:MHC interactions for every instance of IFN-γ elicitation by a T 
cell becomes dangerously redundant. When a T cell can “see” a war going on around it, 
in the form of inflammatory signals, why should it wait for further instructions to act? 
Our results have demonstrated that Th1 respond to IL-18 that is produced in response to 
combined TLR and NLR signaling. This suggests a mechanism for the non-cognate 
stimulation of effector Th1 responses. We further showed that in the absence of this 
response clearance of Salmonella was impaired, establishing that this pathway 
contributes to the normal resolution of infection. 
The information provided here, as well as considerable work in other mechanisms 
(Katsikis et al.), allows us to reconsider the conventional division of innate and adaptive 
immunity in favor of a model in which innate and adaptive immune responses 
communicate and coordinate their responses according to the needs of the circumstances 
(Fig B-1). Developing our understanding of these interactions and overlapping pathways 
further could significantly improve our ability to understand, and ultimately to modify, 
the immune responses required for vaccination and immunotherapeutics, whether 
stimulating the clearance of a granuloma, or suppressing the T cell response in 
autoimmunity. 
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Mechanisms of innate stimulation of T cells 
The signals eliciting production of IFN-γ in various cell types have been studied 
extensively, and yet the complexity of the regulation of this cytokine continues to unfold 
and constantly highlights how much we have left to learn. For example, while T-bet is 
considered to be a master transcriptional regulator of IFN-γ production, in NK cells and 
CD8 T cells Eomes is able to make up for the loss of T-bet, while in CD4 T cells T-bet 
signalling is required (Lazarevic et al., 2013). Further, it was shown that the promoter 
region of IFN-γ that is utilized after TCR signaling is different than the promoter region 
required for IFN-γ production in response to IL-12 and IL-18 (Yang et al., 1999). In 
addition to transcriptional regulation, extensive post-transcriptional regulation of IFN-γ 
mRNA has been shown to take place, and varies between naïve, effector and memory T 
cell populations.  
An activated Th1 cell is primed to produce IFN-γ rapidly, meaning that the IFN-γ gene 
locus is modified to be open for faster transcription, IFN-γ mRNA has been transcribed 
and is ready for rapid translation, and IFN-γ protein has been translated and awaits the 
signals necessary for post-transcriptional modifications and secretion. Despite all of this 
preparation, Th1 do not constitutively secrete IFN-γ. When they receive antigen-specific 
TCR signals, the signaling cascade downstream of the TCR allows rapid release of the 
prepared IFN-γ transcripts and protein from the regulatory mechanisms that otherwise 
keep this production in check. However, other signaling pathways can also stimulate 
IFN-γ production in activated Th1, including IL-12 and IL-18 in combination, as 
mentioned above.  
While some evidence has suggested an ability for innate ligands to interact directly with 
CD4 T cells to stimulate their proliferation or function, it is also likely that innate ligands 
can stimulate T cells through a second messenger that would allow amplification of the 
signal. Many cells are capable of responding to TLR or NLR ligands to produce 
inflammatory cytokines, including those cytokines known to stimulate IFN-γ production 
from Th1 cells. Thus, it is easy to imagine a mechanism whereby Th1 cells respond 
indirectly to innate stimuli by responding to inflammation. In fact, this has been shown to 
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occur during viral infections in response to TLR ligands, and during Salmonella infection 
in response to NLR ligands, both in CD8 T cells (Kupz et al., 2013; Raué et al., 2004). 
Here, we define a mechanism for innate Th1 stimulation that relies on the convergence of 
both TLR and NLR signaling pathways to elicit IL-18 production, which can then be 
recognized by activated Th1 to result in IFN-γ secretion (Fig B-2). Further, while 
previous work has typically focused on very small populations of responding T cells, we 
showed that Th1 cells in an infectious model of strong Th1 activation are highly 
susceptible to innate stimulation, with a large proportion of the Th1 capable of secreting 
IFN-γ in response to LPS stimulation. Finally, we demonstrated that mice whose T cells 
lack the capacity to be innately stimulated suffer a reduced capacity to clear Salmonella 
infection. Together, this suggests a pathway which not only can occur, but must occur for 
normal immune function. We discuss this distinction further in the next section. 
Checks and balances: the significance of adaptive cells with innate functions 
The strict rules governing conventional T cell activation as outlined in the introduction 
are an important checkpoint to prevent unnecessary inflammation and host damage. 
However, under certain circumstances a rapid response to clear and present danger is 
required. While these rapid responses are initiated by the conventional innate immune 
response, the innate response is not always sufficient in strength or duration to combat 
severe infection. Under these circumstances, the development of the adaptive immune 
response is critical. However, the specificity and strength of these responses typically 
comes at a cost. Strong adaptive immune responses require time and abundant specific 
antigen, and during severe infection neither may be available. For this reason, it is easy to 
imagine that mechanisms might need to be in place that would allow a less cautious 
approach to a strong inflammatory response when a crisis occurs. It is equally easy to 
imagine how this might backfire. 
Conventional literature on the subject of innate T cell responses has tended to focus on it 
more as a phenomenon than a function, although the CD8 T cell literature certainly 
contains exceptions (Berg et al., 2003; Berg and Forman, 2006). Th1 cells responding to 
TCR-independent signals were not typically thought of as an alternative response 
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pathway, but as ‘bystanders’ of the actual response going on around them. The term 
bystander itself connotes an effect which is unintentional or unplanned. Given the 
magnitude of these responses, and the similarity to other described ‘innate-like’ 
pathways, it seems unlikely that this stimulation is merely coincidental. More likely, this 
response is a programmed component of the normal T cell effector function. When 
cognate interactions are not sufficient, as detailed in the introduction, a non-cognate 
response could amplify critical effector functions. In a crisis, as recognized by the 
presence of microbes and damage that lead to specific inflammatory signals, like IL-18, 
the ability to “shoot first, and ask questions later” may allow Th1 cells at sites of 
infection to engage in the battle surrounding them earlier and more effectively (Fig B-3). 
For every answer, new questions 
While this and other recent work have established the foundation of a mechanism and 
function for an innate T cell stimulation response pathway, our current knowledge is 
really only the beginning. The ability to elicit effector functions from T cells without 
specific antigen could have broad clinical implications, but before we can begin to 
address these applications we need a thorough understanding mechanistically and 
functionally of how this response differs from the conventional T cell responses 
described. We’ll discuss some specific examples of these questions in three parts: first 
looking at some mechanistic questions that remain to be resolved, then addressing some 
key functional questions, before finally asking how understanding of this pathway can be 
applied to clinical problems. 
As mentioned earlier, one key question surrounding innate T cell stimulation is the 
impact these signals have on the cell fate decision, as compared to conventional TCR 
stimulation. While some work to address CD8 T cell fate decisions has been done, there 
is currently a limited understanding of CD4 T cell fate decisions in general, whether by 
TCR stimulation or otherwise. Thus, learning how and when an individual T cell decides 
between apoptosis and memory, short or long-term memory, central or effector memory, 
and what other options might be available, is still a critical question of basic T cell 
biology. How innate stimulation may factor into these decisions will be an important 
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piece of this puzzle. Further, the extent to which there is plasticity in these decisions 
remains to be answered, as do the requirements for reactivation, as detailed in the 
introductory figure A-5. Current work in CD8 T cells suggests that memory CD8 T cells 
can be reactivated by innate stimuli alone, but the significant decrease in the response 
kinetics we observed in chapter 1 after Salmonella clearance raises questions about the 
response of memory CD4 T cells. It is possible that at least an initial TCR signal is 
required to reactivate these memory cells, after which they may again be restimulated by 
innate signals. It is also possible that in the absence of infection there are simply 
insufficient NLR stimuli available to partner with the TLR signals. 
NLR stimulation is itself an area that requires further exploration, both in this mechanism 
of T cell stimulation, and in general. While it is well established that Salmonella infection 
triggers NLRC4 and NLRP3 inflammasome activation (Broz et al., 2010), it is less clear 
how an endosomal pathogen is recognized by a cytoplasmic receptor. It has been 
proposed that microbial ligands may enter the cytosol alongside the effector molecules 
injected by the Type-III secretion system (T3SS), and indeed some NLRs recognize 
components of the T3SS needle complex itself (Broz and Monack, 2013; Sun et al., 
2007). However, more studies are needed to determine whether the requirement for 
NLRC4 and NLRP3 in innate T cell activation is T3SS-dependent, or whether there is an 
alternative mechanism of inflammasome activation involved.  
Another key point mentioned earlier is the involvement of other CD4 T cell subsets. 
While our work has focused on elicitation of IFN-γ from Th1 cells, there are a myriad of 
possibilities for the role of this same innate stimulation pathway in other CD4 T cells. It 
is certainly possible that this mechanism uniquely affects Th1 cells, among the CD4 T 
cells. However, a far more interesting scenario would involve different innate stimulation 
mechanisms within different CD4 subsets. For example, given the role of IL-1 in the 
Th17 response, a similar role for TLR and NLR driven IL-1β production in the innate 
stimulation of Th17 cells could be hypothesized. Further, while IL-33 is not a caspase 
matured cytokine, some believe that its release from the cell is itself a danger signal 
because of its role in the nucleus. Since IL-33 is known to act upon Th2 cells, this 
 Conclusion 
 87 
cytokine could also mediate stimulation in this subset. In this manner, one could imagine 
a set of cytokine signals capable of mediating the innate stimulation of each CD4 T cell 
subset. Within the Th1 subset itself it is possible that additional signals are present that 
can act alongside the IL-18 and IL-33 responses we observed here. As mentioned earlier, 
in CD8 T cells a diverse mix of cytokine signals were shown to elicit some level of 
response from effector or memory CD8 T cells in vitro (Freeman et al., 2012). A 
similarly comprehensive look at cytokine stimulation in different CD4 T cell subsets 
could prove useful as a first step in defining the potential applicability of this response 
pathway across CD4 T cell subsets. 
Finally, although we previously showed that activated CD4 T cells could be transferred 
into MHC-II-deficient recipients and still be stimulated to produce IFN-γ after LPS 
administration (Srinivasan et al., 2007), the exact contributions and timing of TCR and 
cytokine signals remains to be elaborated upon. TCR engagement alone has been shown 
to be sufficient for stimulation (McLachlan et al., 2009), and stimulation by cytokines in 
the absence of MHC-II: TCR engagement was sufficient, but whether these interactions 
can act synergistically, whether the timing of these interactions is a factor, and whether 
any of these considerations influence functionality, epigenetic programming, apoptosis, 
or memory fate decisions, are all questions that remain to be considered.  
In addition to questions about the mechanisms controlling these innate T cell responses, 
many questions are raised by the existence of this response pathway as to what functions 
it serves. Addressing many of these questions would require a deeper understanding of 
the mechanistic questions outlined above, but here we briefly consider some of the 
functional questions that can now be asked with our current understanding of how innate 
Th1 stimulation occurs. First, while numerous groups have looked at non-cognate 
restimulation of memory CD8 T cells, whether non-cognate restimulation of CD4 T cells 
is an important component of the rapid secondary immune response is unknown. Using 
our Lck-MyD88f/f mice we can potentially address the role of this response upon re-
challenge with virulent Salmonella. Given our limited understanding at this time of the 
effects of innate stimulation on memory formation, any efforts to interrogate the 
 Conclusion 
 88 
secondary response will come with caveats. The inducible cre system offers one possible 
solution to this problem. 
Further, while we have interrogated this response in Salmonella, the functional relevance 
of this pathway in other infection models remains to be proven. Within the context of 
innate Th1 responses, any intracellular infection requiring IFN-γ could be hypothesized 
to require this innate pathway. If the mechanism is expanded to other T cell subsets, than 
it could be presumed that the immune response to a wide variety of infections might 
require this pathway. Moreover, the ability to elicit non-cognate effector functions makes 
exploration of a role in co-infection and polymicrobial infection models seem promising. 
Infection with a first Th1-activating infection (A) could conceivably protect against a 
second (B), as the already activated A-specific Th1 cells respond to the early innate 
recognition of B ligands. 
Finally, while we have focused on Th1 stimulation in a model for which increased IFN-γ 
production has been shown to be beneficial, the potential misuse of these same pathways 
needs to be explored. In particular, during highly inflammatory infections, to what extent 
does the innate T cell response contribute to immunopathology. Further, could innate T 
cell stimulation be responsible for some of the T cell-mediated autoimmune conditions 
described, and if so, how do the responses in these patients differ from responses in 
healthy patients? It is important to understand the functions of these responses, both 
positive and negative, before we can really begin to appreciate the applications of this 
knowledge. 
Ultimately, we ask all of these questions for a better understanding of how this 
information can be applied practically. How can our knowledge be used to improve or 
suppress the system, and when do we do each? The simplest practical application for 
these findings relates to a common lab technique. In assays of T cell function it is 
common to add antigen, either to a culture or in vivo, to assess the effector response to 
stimulation. When the antigen is unknown, or a polyclonal response is desired, often this 
antigen stimulation is administered in the form of a heat-killed or otherwise inactivated 
microbe. It is important to realize that these methods would include not only T cell 
 Conclusion 
 89 
antigens, but also a great deal of MAMPs. In some cases this distinction could prove 
irrelevant, or even useful, but in other cases the innately stimulated T cells could 
inexplicably confound the results.  
For example, currently to test whether a person is infected with tuberculosis (TB) their 
PBMCs (peripheral blood mononuclear cells) are stimulated with TB antigens and IFN-γ 
production is measured. Recently, it was shown that addition of TLR ligands improves 
the sensitivity of this assay (Gaur et al., 2012). Given the non-cognate nature of the T cell 
stimulation by these ligands, this improved assay may also result in higher false positive 
rates. Individuals with other current (known or unknown) infections would likely have 
activated T cells capable of innate stimulation. Thus, theoretically it might be possible to 
detect anything from a cold to an asymptomatic chlamydia infection by the addition of 
TLR ligands to PBMCs. The potential for the innate T cell response to confound results 
needs to be considered and tested in such cases. 
As a better understanding of these pathways develops it might be feasible to modulate the 
innate T cell response to our benefit. With a better understanding of the mechanism for 
development and restimulation of memory T cells, and the function of these cells in the 
secondary response, it could be possible some day to tailor vaccine design around the 
development of stronger innate T cell responses. Further, potential immunotherapeutics 
could be designed to improve or suppress particular T cell functions. For example, a more 
targeted treatment to clear mycobacterial granulomas with less toxicity than directly 
administered IFN-γ. Conversely, monoclonal antibodies against IL-18 could prove useful 
for autoimmune conditions in which Th1 cells are being activated by non-cognate 
stimuli. 
Overall, we are just beginning to understand the significance of this response pathway. 
As more and more details unfold as to how these T cells are stimulated innately and what 
purposes this innate stimulation serves, more opportunities to alter these responses will 
become apparent. 
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Figure B-2: Mechanism of Th1 response to innate stimuli 
CD4 T cells are activated by direct interaction with APCs in the secondary lymph tissues. These 
effector cells migrate to sites of infection, where they require additional stimulation to provoke 
effector cytokine secretion. Although conventional wisdom describes this signal as an additional 
direct interaction with an APC, the data here supports an alternative mechanism of Th1 cell 
stimulation. We propose that signals from TLR recognition of conserved microbial ligands and 
NLR recognition of intracellular infection or cell damage converge, resulting in the secretion of 
IL-18. Stimulation of Th1 after administration of the TLR ligand LPS required Th1-intrinsic 
expression of the IL-18R. Together, these data suggest a model wherein non-cognate stimulation 
of Th1 cells can occur in the presence of both TLR and NLR signals, bypassing an adaptive 
checkpoint under critical inflammation. 
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Figure B-3: Optimal Th1 responses require both innate and adaptive immune signals 
This illustration highlights the ability of Th1 cells to communicate and cooperate with both the 
adaptive and innate arms of the immune system for optimal function. In the center, a blue Th1 
cell recently emigrated from a lymph node in which conventional T cell activation signals were 
received encounters inflammatory signals (yellow) generated in response to TLR (pink) and 
inflammasome signaling (yellow, orange, and green) by an innate cell (orange) at the site of 
infection. These inflammatory signals allow the Th1 cell to rapidly recognize and respond to an 
ongoing crisis. The Th1 cell secretes its own signals (blue), such as IFN-γ, to activate other cells 
in the vicinity. A nearby macrophage (yellow) is warned to ‘prepare for battle’. 
 
 
Materials and Methods 
Mice 
C57BL/6, B6.SJL-PtprcaPepcb/BoyJ, B6.PL-Thy1a/CyJ, TLR4-deficient, and IL-18R-
deficient mice were purchased from The Jackson Laboratory or NCI at 6-8 weeks of age. 
MyD88-, IL-1R1-, and IFN-γR-deficient C57BL/6 mice were obtained from Dr. Jenkins 
(University of Minnesota) and Dr. Way (University of Cincinnati), and bred in our 
animal facility. IL-33R-deficient C57BL/6 mice were kindly provided by Dr. Bryce 
(Northwestern University). Mice deficient in NLRC4 and NLRP3 were maintained at 
Stanford University (Broz et al., 2010). T cell specific Myd88 deficient mice were 
generated as illustrated in Figure C-1 by crossing Lck-cre mice to Myd88loxP/loxP flanked 
mice purchased from Jackson labs. Mice were genotyped by PCR according to protocols 
provided by The Jackson Laboratory. All animal procedures were approved by UC Davis 
IACUC (#16612) and University of Minnesota IACUC (#0801A25442). 
Bacterial strains, culture and infection 
Bacterial strains used for this work are listed in Table C-1. Aflagellate Salmonella 
enterica serovar Typhimurium strain BRD509 was modified by Sean-Paul Nuccio as 
detailed below to generate aflagellate BRD509. Unless otherwise indicated, all mice were 
given 5x105 cfu bacteria intravenously (i.v.). Prior to infection, all Salmonella was grown 
overnight at 37°C in static Luria-Bertani (Becton Dickinson) broth culture. Concentration 
of overnight culture was determined by spectrophotometry at OD600  and bacteria were 
diluted in sterile 1X PBS (phosphate buffered saline, Gibco) to the appropriate 
concentration for administration in 200µl total volume. All samples used for infection 
were titrated and plated on MacConkey agar (Becton Dickinson) to confirm administered 
bacterial dose. 
Chlamydia muridarum strain Nigg II was purchased from ATCC and was cultured and 
quantitated by Linxi Li within HeLa 229 cells grown in Dulbecco’s modified Eagle’s 
medium (Life Technologies) supplemented with 10% fetal bovine serum. Elementary 
bodies  (EBs) were purified by discontinuous density gradient centrifugation and stored at 
-80°C, as previously described (Scidmore, 2005). Purified EBs were enumerated for 
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inclusion-forming units by infecting HeLa 229 cells and counting inclusions stained with 
anti-Chlamydia MOMP. A fresh aliquot was thawed for each infection, in which 1x107 
EBs were administered i.v. in 1X sterile PBS (Gibco).  
Generation of aflagellate strain SPN529 
Bacteriophage P22 (HT105/1 int-201) was utilized for transduction. Transductants were 
purified from phage P22 on EBU agar and confirmed to be P22-sensitive by cross-
streaking colonies against P22-H5. A flagellin-deficient mutant of BRD509 was 
generated by transducing the fliC5050::MudJ insertion of SPN286 into BRD509 and 
selecting for kanamycin-resistant transductants, yielding SPN527. The fljB5001::MudCm 
of SPN287 was transduced into SPN527 by selecting for chloramphenicol-resistant 
mutants, yielding SPN529. SPN529 was confirmed to be non-motile relative to BRD509 
by stabbing in motility agar and incubating at 37oC for 24 hours.  
Quantification of bacterial loads 
Mice were euthanized and the indicated organs collected in HBSS (Hank’s balanced salt 
solution) or PBS (both Gibco) on ice, homogenized, and reconstituted in a known volume 
of HBSS or PBS. Samples were mixed thoroughly and serial 1:10 dilutions were plated 
on MacConkey agar (Becton Dickinson) plates, incubated overnight at 37oC, and 
enumerated the following day to calculate the number of colony forming units (cfu) in the 
total organ. 
Flow cytometry 
For flow cytometry, cells were prepared as a single cell suspension of between 1x106 and 
8x106 cells/ml and stained with various antibodies from eBioscience, Becton Dickinson 
(BD), or Tonbo Biosciences, for 30 minutes to 1 hour in Fc block on ice. Intracellular 
cytokine or transcription factor staining was performed using the Foxp3 intra-nuclear 
staining kit from eBioscience, as recommended by the manufacturer. Stained cells were 
analyzed using a FACS Canto, Aria or Fortessa (BD) using appropriate compensation 
controls and flow cytometry data was analyzed using FlowJo software (TreeStar).  
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Bone marrow chimeras 
Mixed bone marrow chimeras were generated as illustrated in Figure C-2 by first 
irradiating 45.1+ congenic mice (B6.SJL)  (1000 rads irradiation by cesium source). The 
following day, bone marrow was isolated from congenic CD90.1+ (B6.PL) and 
genetically-deficient mouse femurs and tibias, cells counted by hematocytometer, and 
then the bone marrow cells were combined at a 1:1 ratio before being administered 
(4x106 total cells) in 200µl 1X PBS (Gibco). After bone marrow transfer, chimeras were 
maintained on antibiotics for at least 4 weeks and blood collected at 4 weeks post-transfer 
for flow cytometric analysis of immune reconstitution. Chimeras were infected 6-8 weeks 
after administration of bone marrow, and at least 2 weeks after discontinuation of 
antibiotic treatment.  
In vivo administration of TLR ligands 
Ultrapure lipopolysaccharide (LPS) from E. coli strain EH100Rα (Alexis, TLRgrade®), 
purified bacterial flagellin, endotoxin-free Pam3CSK4, CpG DNA (ODN1585), and 
Imiquimod (all Invivogen) were diluted in 1X PBS (UltraPure PBS, Gibco) and 
administered i.v. to mice. Spleens and livers were harvested from infected or uninfected 
mice 4 hours or less after administration of MAMPs. Flagellin was purified from an LPS-
deficient X4700 strain of S. Typhimurium using a modified acid-shock protocol and 
passed multiple times through Detoxi-Gel columns (Thermo Scientific) to remove 
residual endotoxin, as previously described (Salazar-Gonzalez et al., 2007).  
RNA preparation, RT-QPCR, and microarray 
RNA was extracted from cryopreserved spleens and livers according to the 
manufacturer’s instructions using TRIzol reagent (Ambion) and quantified using a 
Nanodrop spectrophotometer (Thermo Scientific). RNA was DNase-treated using a 
DNA-free kit (Ambion), re-quantified using the Nanodrop, diluted to a stock 
concentration in sterile RNAse-free water (Gibco), and stored at -80°C for future use in 
RT-QPCR or microarray.  
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For RT-QPCR, a SensiFAST SYBR Hi-ROX One-Step RT-QPCR kit (Bioline) was used 
for both cDNA synthesis and QPCR reactions using 100ng total RNA per reaction. RT-
QPCR was performed on a 7900HT Fast Real-Time PCR System (Applied Biosystems) 
in a 96 well plate and triplicate data was analyzed in Microsoft Excel by the comparative 
Ct method (Applied Biosystems) using GAPDH (glyceraldehyde-3-phosphate 
dehydrogenase) as the control. Data is expressed as fold change of stimulated over 
unstimulated ΔCt. Primer sequences and their references are listed in Table C-2. 
Serum Cytokine ELISAs 
Sera was prepared by collecting blood from retro-orbitally exsanguinated, anesthetized 
mice that had been infected or stimulated as indicated, then blood was incubated on ice to 
allow clotting, centrifuged, and serum harvested and stored at -20°C. Cytokine ELISAs 
for IFN-γ, IL-12 and IL-33 were performed by Oanh Pham according to the instructions 
provided by the Ready-Set-Go kit (eBioscience) and concentrations determined using the 
protein standard provided. For the IL-18 ELISA, the same standard protocol was 
followed using capture and detection antibodies (Medical and Biological Labs, Co) as 
recommended by the manufacturer with rmIL-18 as a standard (R&D). After substrate 
was added, plates were read at 450nm using a microplate reader (Spectra Max M2, 
Molecular Devices, Inc) and analyzed in Microsoft Excel. 
Antibody depletion of CD4+ and CD8+ T cells 
Loss of CD4+, CD8+, or CD4+ and CD8+ T cells was examined in vivo by depletion of 
cells with indicated rat anti-mouse monoclonal antibodies (BioXCell). Antibodies were 
administered intraperitoneally twice per week starting at day 7 and depletions were 
maintained until euthanization. The initial doses (days 7 and 10) contained 200 µg of 
antibody per mouse, all subsequent doses contained 300 µg per mouse. Maintenance of 
depletion was monitored by flow cytometry on blood collected once per week from the 
lateral tail vein. 
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Statistical Analyses 
All statistical analyses were performed as described in the figure legends using Prism 
version 5 (Graphpad). All error bars are displayed as mean +/- SEM. P< 0.005 (***), p< 
0.01 (**), p<0.05 (*) or p>0.05 (ns). 
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Designation Relevant genotype Source 
S. Typhimurium 
BRD509 SL1344 ∆aroA ∆aroD (Strugnell et 
al., 1992) 
SPN286 IR715 fliC5050::MudJ (Winter et al., 
2009) 
SPN287 IR715 fljB5001::MudCm (Winter et al., 
2009) 
SPN527 SL1344 ∆aroA ∆aroD fliC5050::MudJ (O'Donnell et 
al., 2014) 
SPN529 SL1344 ∆aroA ∆aroD fliC5050::MudJ 
fljB5001::MudCm 
(O'Donnell et 
al., 2014) 
C. muridarum 
Nigg II  ATCC 
 
Table C-1: Bacterial strains used in this work 
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Primer Forward Sequence (5’ – 3’) Reverse Sequence (5’ – 3’) Reference 
IL12 
p35 AAATGAAGCTCTGCATCCTGC TCACCCTGTTGATGGTCACG 
(Liu et al., 
2004) 
IL18 CAGGCCTGACATCTTCTGCAA CTGACATGGCAGCCATTGT 
(Abu Elhija 
et al., 
2008) 
IL33 GGTGTGGATGGGAAGAAGCTG 
GAGGACTTTTTGTGAAGGAC
G 
(Talabot-
Ayer et al., 
2012) 
IFN-γ TCAAGTGGCATAGATGTGGAAGAA 
TGGCTCTGCAGGATTTTCAT
G 
(Godinez 
et al., 
2008) 
Gapdh ACGGCCGCATCTTCTTGTGCA AATGGCAGCCCTGGTGACCA 
(Talabot-
Ayer et al., 
2012) 
 
Table C-2: Primers used for RT-QPCR 
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Figure C-1: A conceptual schematic for the generation of Lck-MyD88f/f mice 
MyD88-loxP mice are bred to Lck-cre mice to yield F1 offspring that are heterozygous for both 
the cre recombinase gene and MyD88-loxP (MyD88f/w). These mice are then crossed a second 
time to MyD88-loxP mice (cre negative), resulting in offspring that are either heterozygous (cre 
+) or negative for Lck-cre, and MyD88f/f or MyD88f/w. Cre + mice are shown as Lck-MyD88f/f 
(MyD88-deficient T cells) or Lck-MyD88f/w (littermate controls) in the text.  
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Figure C-2: Making mixed bone marrow chimeras 
The diagram shows how mixed bone marrow chimeras are created, as detailed in the methods, 
and the gating strategy used during flow cytometry to analyze the populations of cells coming 
from separate mice. Briefly, a congenically marked recipient mouse is irradiated, then the 
following day bone marrow is isolated from 2 different congenically marked donors and mixed in 
equal proportion before i.v. administration to the irradiated recipient. After six weeks, the donor 
marrow has reconstituted the irradiated recipient as a chimera of all three populations, as seen in 
the flow cytometry gating.  
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